Poly-ε-caprolactone (PCL), a promising polymer for pharmaceutical and biomedical applications: Focus on nanomedicine in cancer

References

• Godage, R.; Chaudhari, A. Advanced drug delivery systems; Techmax Publication: Pune, 2017.
   Google Scholar
• Sinha, V. R.; Bansal, K.; Kaushik, R.; Kumria, R.; Trehan, A. Poly-ϵ-caprolactone microspheres and nanospheres: an overview. Int. J. Pharm. 2004, 278, 1–23. DOI: 10.1016/j.ijpharm.2004.01.044.
   PubMed Web of Science ®Google Scholar
• Woodruff, M. A.; Hutmacher, D. W. The return of a forgotten polymer—Polycaprolactone in the 21st century. Prog. Polym. Sci. 2010, 35, 1217–1256. DOI:10.1016/j.progpolymsci.2010.04.002.
   Web of Science ®Google Scholar
• Sivabalan, A.; Subramani, R. H.; Meenarathi, B.; Palanikumar, S.; Anbarasan, R. Synthesis and Characterization of poly(ε-caprolactone): A comparative study. Int. J. Sci. Res. Eng. Technol. 2014, 1, 9–14.
   Google Scholar
• Dash, T. K.; Konkimalla, V. B. Poly-J-caprolactone based formulations for drug delivery and tissue engineering: A review. J. Controlled Release 2012,158, 15–33. DOI: 10.1016/j.jconrel.2011.09.064.
   PubMed Web of Science ®Google Scholar
• Kumari, A.; Yadav, S. K.; Yadav, S. C. Biodegradable polymeric nanoparticles based drug delivery systems. Colloids Surf., B 2010,75, 1–18. DOI: 10.1016/j.colsurfb.2009.09.001.
   PubMed Web of Science ®Google Scholar
• Palamà, I. E.; Arcadio, V.; D’Amone, S.; Biasiucci, M.; Gigli, G.; Cortese, B. Therapeutic PCL scaffold for reparation of resected osteosarcoma defect. Sci. Rep. 2017,7, 12672. DOI: 10.1038/s41598-017-12824-3.
   PubMed Web of Science ®Google Scholar
• Rai, B.; Teoh, S. H.; Hutmacher, D. W.; Cao, T.; Ho, K. H. Novel PCL-based honeycomb scaffolds as drug delivery systems for rhBMP-2. Biomaterials 2005,26, 3739–3748. DOI: 10.1016/j.biomaterials.2004.09.052.
   PubMed Web of Science ®Google Scholar
• Singh, M.; Manikandan, S.; Kumaraguru, A. K. Nanoparticles: a new technology with wide applications. Res. J. Nanosci. Nanotechnol. 2010, 1, 1–11. DOI: 10.3923/rjnn.2010.
   Google Scholar
• Pelaz, B.; Alexiou, C.; Alvarez-Puebla, R. A.; Alves, F.; Andrews, A. M.; Ashraf, S.; Balogh, L. P.; Ballerini, L.; Bestetti, A.; Brendel, C.; et al. Diverse Applications of Nanomedicine. ACS Nano. 2017, 11, 2313–2381. DOI: 10.1021/acsnano.6b06040.
   PubMed Web of Science ®Google Scholar
• Singh, S. Nanomedicine-Nanoscale Drugs and Delivery Systems. J. Nanosci. Nanotechnol. 2010, 10, 7906–7918.DOI: 10.1166/jnn.2010.3617.
   PubMed Web of Science ®Google Scholar
• Forman, D.; Ferlay, J. The global and regional burden of cancer. In World cancer report 2014, 1st ed.; Stewart, B. W., Wild, C. P., Eds.; International Agency for Research on Cancer: Lyon, 2014; pp 16–53.
   Google Scholar
• Torre, L. A.; Bray, F.; Siegel, R. L.; Ferlay, J.; Lortet-Tieulent, J.; Jemal, A. Global cancer statistics, 2012. CA Cancer J. Clin. 2015, 65, 87–108. DOI: 10.3322/caac.21262.
   PubMed Web of Science ®Google Scholar
• Sinha, R.; Kim, G. J.; Nie, S.; Shin, D. M. Nanotechnology in cancer therapeutics: bioconjugated nanoparticles for drug delivery. Mol. Cancer Ther. 2006, 5, 1909–1917. DOI: 10.1158/1535-7163.
   PubMed Web of Science ®Google Scholar
• Wilczewska, A. Z.; Niemirowicz, K.; Markiewicz, K. H.; Car, H. Nanoparticles as drug delivery systems. Pharmacol. Rep. 2012, 64,1020–1037. DOI: 10.1016/S1734-1140(12)70901-5.
   PubMed Web of Science ®Google Scholar
• Nakache, E.; Poulain, N.; Candau, F.; Orecchioni, A.-M.; Irache, J. M. Biopolymer and polymer nanoparticles and their biomedical applications. In Handbook of Nanostructured Materials and Nanotechnology: Organics, polymers, and biological materials, 1st ed.; Nalwa, H. S., Ed.; Academic Press: Cambridge, 1999; Vol.5, pp 577–635.
   Google Scholar
• Singh, R.; Lillard, J. W.Jr. Nanoparticle-based targeted drug delivery. Exp. Mol. Pathol. 2009, 86, 215–223. DOI: 10.1016/j.yexmp.2008.12.004.
   PubMed Web of Science ®Google Scholar
• Panyam, J.; Labhasetwar, V. Biodegradable nanoparticles for drug and gene delivery to cells and tissue. Adv. Drug Delivery Rev. 2003, 55, 329–347. DOI: 10.1016/S0169-409X(02)00228-4.
   PubMed Web of Science ®Google Scholar
• Lee, J. S.; Feijen, J. Polymersomes for drug delivery: Design, formation and characterization. J. Controlled Release2012,161, 473–483. DOI: 10.1016/j.jconrel.2011.10.005.
   PubMed Web of Science ®Google Scholar
• Noriega-Luna, B.; Godínez, L. A.; Rodríguez, F. J.; Rodríguez, A.; Zaldívar-Lelo de Larrea, G.; Sosa-Ferreyra, C. F.; Mercado-Curiel, R. F.; Manríquez, J.; Bustos, E. Applications of Dendrimers in Drug Delivery Agents, Diagnosis, Therapy, and Detection. J. Nanomater.2014, 2014, 1–19. DOI: 10.1155/2014/507273.
   Web of Science ®Google Scholar
• Aliabadi, H. M.; Lavasanifar, A. Polymeric micelles for drug delivery. Expert Opin. Drug Delivery, 2006,3, 139–162. DOI: 10.1517/17425247.3.1.139.
   PubMedGoogle Scholar
• Pinto Reis, C.; Neufeld, R. J.; Ribeiro, A. J.; Veiga, F. Nanoencapsulation I. Methods for preparation of drug-loaded polymeric nanoparticles. Nanomedicine, 2006, 2, 8–21. DOI:10.1016/j.nano.2005.12.003.
   PubMed Web of Science ®Google Scholar
• Nair, L. S.; Laurencin, C. T. Biodegradable polymers as biomaterials. Prog. Polym. Sci. 2007, 32, 762–798. DOI: 10.1016/j.progpolymsci.2007.05.017.
   Web of Science ®Google Scholar
• Shenoy, D. B.; Amiji, M. M. Poly(ethylene oxide)-modified poly(ɛ-caprolactone) nanoparticles for targeted delivery of tamoxifen in breast cancer. Int. J. Pharm. 2005,293, 261–270. DOI: 10.1016/j.ijpharm.2004.12.010.
   PubMed Web of Science ®Google Scholar
• Wei, X.; Gong, C.; Gou, M.; Fu, S.; Guo, Q.; Shi, S.; Luo, F.; Guo, G.; Qiu, L.; Qian, Z. Biodegradable poly(ɛ-caprolactone)–poly(ethylene glycol) copolymers as drug delivery system. Int. J. Pharm. 2009, 381, 1–18. DOI:10.1016/j.ijpharm.2009.07.033.
   PubMed Web of Science ®Google Scholar
• Varan, C.; Bilensoy, E. Cationic PEGylated polycaprolactone nanoparticles carrying post-operation docetaxel for glioma treatment. Beilstein J. Nanotechnol. 2017, 8, 1446–1456. DOI: 10.3762/bjnano.8.144.
   PubMed Web of Science ®Google Scholar
• Pitt, C. G.; Chasalow, F. I.; Hibionada, Y. M.; Klimas, D. M.; Schindler, A. Aliphatic polyesters. I. The degradation of poly(ϵ-caprolactone) in vivo. J. Appl. Polym. Sci. 1981,26, 3779–3787. DOI:10.1002/app.1981.070261124.
   Web of Science ®Google Scholar
• Woodward, S. C.; Brewer, P. S.; Moatamed, F.; Schindler, A.; Pitt, C. G. The intracellular degradation of poly(ε-caprolactone). J. Biomed. Mater. Res., Part A 1985, 19, 437–444. DOI: 10.1002/jbm.820190408.
   Web of Science ®Google Scholar
• Pitt, C. G. Poly-ε-Caprolactone and its Copolymers. In Biodegradable Polymers as Drug Delivery Systems, 1st ed.; Chasin, M., Langer, R., Eds.; Marcel Decker Inc.: New York, 1990; pp 71–120.
   Google Scholar
• Sun, H.; Mei, L.; Song, C.; Cui, X.; Wang, P. The in vivo degradation, absorption and excretion of PCL-based implant. Biomaterials, 2006, 27, 1735–1740. DOI: 10.1016/j.biomaterials.2005.09.019.
   PubMed Web of Science ®Google Scholar
• Vert, M.; Li, S. M.; Spenlehauer, G.; Guerin, P. Bioresorbability and biocompatibility of aliphatic polyesters. J. Mater. Sci.: Mater. Med. 1992, 3, 432–446. DOI: 10.1007/BF00701240.
   Web of Science ®Google Scholar
• Sisson, A. L.; Ekinci, D.; Lendlein, A. The contemporary role of ε-caprolactone chemistry to create advanced polymer architectures. Polymer, 2013, 54, 4333–4350. DOI: 10.1016/j.polymer.2013.04.045.
   Web of Science ®Google Scholar
• Kanehisa, M.; Goto, S.; Kawashima, S.; Nakaya, A. The KEGG databases at GenomeNet. Nucleic Acids Res. 2002, 30, 42–46. DOI: 10.1093/nar/30.1.42.
   PubMed Web of Science ®Google Scholar
• Wishart, D. S.; Feunang, Y. D.; Marcu, A.; Guo, A. C.; Liang, K.; Vázquez-Fresno, R.; Sajed, T.; Johnson, D.; Li, C.; Karu, N.; et al. HMDB 4.0: the human metabolome database for 2018. Nucleic Acids Res. 2018, 46, D608–D617. DOI: 10.1093/nar/gkx1089.
   PubMed Web of Science ®Google Scholar
• Bates, C. J.; Edwards, G.; Downes, R.; Coward, A. [13C]adipic acid as a probe of fatty acid oxidation in human subjects: feasibility study and pilot trial of correction of endemic riboflavin deficiency in The Gambia. J. Nutr. Biochem. 1991, 2, 214–221. DOI: 10.1016/0955-2863(91)90019-2.
   Web of Science ®Google Scholar
• Ulery, B. D.; Nair, L. S.; Laurencin, C. T. Biomedical Applications of Biodegradable Polymers. J. Polym. Sci., Part B: Polym. Phys. 2011, 49, 832–864. DOI: 10.1002/polb.22259.
   PubMed Web of Science ®Google Scholar
• Gatoo, M. A.; Naseem, S.; Arfat, M. Y.; Dar, A. M.; Qasim, K.; Zubair, S. Physicochemical Properties of Nanomaterials: Implication in Associated Toxic Manifestations. Biomed Res. Int. 2014, 2014, 1–8. DOI: 10.1155/2014/498420.
   Web of Science ®Google Scholar
• Chawla, J. S.; Amiji, M. M. Biodegradable poly(ε-caprolactone) nanoparticles for tumor-targeted delivery of tamoxifen. Int. J. Pharm. 2002, 249, 127–138. DOI: 10.1016/S0378-5173(02)00483-0.
   PubMed Web of Science ®Google Scholar
• Funabashi, M.; Ninomiya, F.; Kunioka, M. Biodegradation of Polycaprolactone Powders Proposed as Reference Test Materials for International Standard of Biodegradation Evaluation Method. J. Polym. Environ. 2007, 15, 7–17. DOI: 10.1007/s10924-006-0041-4.
   Web of Science ®Google Scholar
• Gan, Z.; Fung, J. T.; Jing, X.; Wu, C.; Kuliche, W. K. A novel laser light-scattering study of enzymatic biodegradation of poly(ε-caprolactone) nanoparticles. Polymer, 1999, 40, 1961–1967. DOI: 10.1016/S0032-3861(98)00414-5.
   Web of Science ®Google Scholar
• Wu, C.; Jim, T. F.; Gan, Z.; Zhao, Y.; Wang, S. A heterogeneous catalytic kinetics for enzymatic biodegradation of poly(ϵ-caprolactone) nanoparticles in aqueous solution. Polymer 2000, 41, 3593–3597. DOI: 10.1016/S0032-3861(99)00586-8.
   Web of Science ®Google Scholar
• Chen, D. R.; Bei, J. Z.; Wang, S. G. Polycaprolactone microparticles and their biodegradation. Polym. Degrad. Stab. 2000, 67, 455–459. DOI: 10.1016/S0141-3910(99)00145-7.
   Web of Science ®Google Scholar
• Hoshino, A.; Isono, Y. Degradation of aliphatic polyester films by commercially available lipases with special reference to rapid and complete degradation of poly(L-lactide) film by lipase PL derived from Alcaligenes sp. Biodegradation, 2002, 13, 141–147. DOI:10.1023/A:1020450326301.
   PubMed Web of Science ®Google Scholar
• Gan, Z.; Liang, Q.; Zhang, J.; Jing, X. Enzymatic degradation of poly(ε-caprolactone) film in phosphate buffer solution containing lipases. Polym. Degrad. Stab. 1997, 56, 209–213. DOI:10.1016/S0141-3910(96)00208-X.
   Web of Science ®Google Scholar
• Martins, A. M.; Pham, Q. P.; Malafaya, P. B.; Sousa, R. A.; Gomes, M. E.; Raphael, R. M.; Kasper, F. K.; Reis, R. L.; Mikos, A. G. The Role of Lipase and α-Amylase in the Degradation of Starch/Poly(ɛ-Caprolactone) Fiber Meshes and the Osteogenic Differentiation of Cultured Marrow Stromal Cells. Tissue Eng., Part A, 2009, 15, 295–305. DOI:10.1089/ten.tea.2008.0025.
   PubMed Web of Science ®Google Scholar
• Tietz, N. W.; Shuey, D. F. Lipase in serum–the elusive enzyme: an overview. Clin. Chem. 1993, 39, 746–756.
   PubMed Web of Science ®Google Scholar
• Jenkins, M. J.; Harrison, K. L. The effect of crystalline morphology on the degradation of polycaprolactone in a solution of phosphate buffer and lipase. Polym. Adv. Technol. 2008, 19, 1901–1906. DOI:10.1002/pat.1227.
   Web of Science ®Google Scholar
• Surnar, B.; Jayakannan, M. Structural Engineering of Biodegradable PCL Block Copolymer Nanoassemblies for Enzyme-Controlled Drug Delivery in Cancer Cells. ACS Biomater. Sci. Eng. 2016, 2, 1926–1941. DOI: 10.1021/acsbiomaterials.6b00310.
   PubMed Web of Science ®Google Scholar
• Surnar, B.; Jayakannan, M. Triple Block Nanocarrier Platform for Synergistic Cancer Therapy of Antagonistic Drugs. Biomacromolecules, 2016, 17, 4075–4085. DOI: 10.1021/acs.biomac.6b01608.
   PubMed Web of Science ®Google Scholar
• Orts-Gil, G.; Natte, K.; Österle, W. Multi-parametric reference nanomaterials for toxicology: state of the art, future challenges and potential candidates. RSC Adv. 2013, 3, 18202–18215. DOI: 10.1039/C3RA42112K.
   Web of Science ®Google Scholar
• Kariduraganavar, M. Y.; Kittur, A. A.; Kamble, R. R. Polymer Synthesis and Processing. In Natural and Synthetic Biomedical Polymers, 1st ed.; Kumbar, S. G., Laurencin, C. T., Deng, M., Eds.; Elsevier Inc.: Burlington, 2014; pp 1–31.
   Google Scholar
• Heiny, M.; Wurth, J. J.; Shastri, V. P. Progress in Functionalized Biodegradable Polyesters. In Natural and Synthetic Biomedical Polymers, 1st ed.; Kumbar, S. G., Laurencin, C. T., Deng, M., Eds.; Elsevier Inc.: Burlington, 2014; pp 167–180.
   Google Scholar
• Jenkins, M. J.; Harrison, K. L. The effect of molecular weight on the crystallization kinetics of polycaprolactone. Polym. Adv. Technol. 2006, 17, 474–478. DOI: 10.1002/pat.733.
   Web of Science ®Google Scholar
• Bordes, C.; Fréville, V.; Ruffin, E.; Marote, P.; Gauvrit, J. Y.; Briançon, S.; Lánteri, P. Determination of poly(ɛ-caprolactone) solubility parameters: Application to solvent substitution in a microencapsulation process. Int. J. Pharm. 2010, 383, 236–243. DOI: 10.1016/j.ijpharm.2009.09.023.
   PubMed Web of Science ®Google Scholar
• Lide, D. R. CRC Handbook of Chemistry and Physics, CRC Press: Boca Raton, 2003.
   Google Scholar
• Akitake, B.; Spelbrink, R. E.; Anishkin, A.; Killian, J. A.; de Kruijff, B.; Sukharev, S. 2,2,2-Trifluoroethanol Changes the Transition Kinetics and Subunit Interactions in the Small Bacterial Mechanosensitive Channel MscS. Biophys. J.2007, 92, 2771–2784. DOI:10.1529/biophysj.106.098715.
   PubMed Web of Science ®Google Scholar
• Wagner, F. S. Jr. Acetyl Chloride. In Kirk-Othmer Encyclopedia of Chemical Technology, 4th ed.; Howe-Grant, M., Kroschwitz, J. I., Eds.; Wiley: New York, 1991; Vol.1, pp 155–157.
   Google Scholar
• Labet, M.; Thielemans, W. Synthesis of polycaprolactone: a review. Chem. Soc. Rev. 2009, 38, 3484–3504. DOI: 10.1039/B820162P.
   PubMed Web of Science ®Google Scholar
• Azimi, B.; Nourpanah, P.; Rabiee, M.; Arbab, S. Poly(ε-caprolactone) Fiber: An overview. J. Eng. Fibers Fabr. 2014, 9, 74–90.
   Web of Science ®Google Scholar
• Clark, E.; Childers, C. W. Impact-resistant plastics from blends of poly(styrene/acrylonitrile) with ϵ-caprolactone block copolymers. J. Appl. Polym. Sci. 1978, 22, 1081–1092. DOI: 10.1002/app.1978.070220417.
   Web of Science ®Google Scholar
• Manzini, G.; Crescenzi, V. Heat of dilution and density data for poly(β-propiolactone) and poly(ε-caprolactone) in dioxane. Polymer, 1973, 14, 343–346. DOI: 10.1016/0032-3861(73)90017-7.
   Web of Science ®Google Scholar
• Ketelaars, A.A.J.; Papantoniou, Y.; Nakayama, K. Analysis of the density and the enthalpy of poly(ϵ-caprolactone)-polycarbonate blends: Amorphous phase compatibility and the effect of secondary crystallization. J. Appl. Poly. Sci. 1997, 66, 921–927. DOI: 10.1002/(SICI)1097-4628(19971031)66:5 < 921::AID-APP12 > 3.0.CO;2-Q.
   Web of Science ®Google Scholar
• Lebedev, B.; Yevstropov, A. Thermodynamic properties of polylactones. Macromol. Chem. Phys. 1984, 185, 1235–1253. DOI: 10.1002/macp.1984.021850617.
   Web of Science ®Google Scholar
• Gautam, S.; Dinda, A. K.; Mishra, N. C. Fabrication and characterization of PCL/gelatin composite nanofibrous scaffold for tissue engineering applications by electrospinning method. Mater. Sci. Eng. C Mater. Biol. Appl. 2013, 33, 1228–1235. DOI: 10.1016/j.msec.2012.12.015.
   PubMed Web of Science ®Google Scholar
• Wu, C.-S. Physical properties and biodegradability of maleated-polycaprolactone/starch composite. Polym. Degrad. Stab. 2003, 80, 127–134. DOI: 10.1016/S0141-3910(02)00393-2.
   Web of Science ®Google Scholar
• Wu, C.-S. A comparison of the structure, thermal properties, and biodegradability of polycaprolactone/chitosan and acrylic acid grafted polycaprolactone/chitosan. Polymer, 2005, 46, 147–155. DOI: 10.1016/j.polymer.2004.11.013.
   Web of Science ®Google Scholar
• Cama, G.; Mogosanu, D. E.; Houben, A.; Dubruel, P. Synthetic biodegradable medical polyesters: poly-ε-caprolactone. In Science and Principles of Biodegradable and Bioresorbable Medical Polymers: Materials and Properties, 1st ed.; Zhang, X., Ed.; Woodhead Publishing: Cambridge, 2016; pp 79–105
   Google Scholar
• Mahapatro, A.; Kumar, A.; Gross, R. A. Mild, Solvent-Free ω-Hydroxy Acid Polycondensations Catalyzed by Candida antarctica Lipase B. Biomacromolecules, 2004,5, 62–68. DOI:10.1021/bm0342382.
   PubMed Web of Science ®Google Scholar
• Dong, H.; Wang, H.-D.; Cao, S.-G.; Shen, J.-C. Lipase-catalyzed polymerization of lactones and linear hydroxyesters. Biotechnol. Lett. 1998, 20, 905–908. DOI: 10.1023/A:1005441707356.
   Web of Science ®Google Scholar
• Braud, C.; Devarieux, R.; Atlan, A.; Ducos, C.; Vert, M. Capillary zone electrophoresis in normal or reverse polarity separation modes for the analysis of hydroxy acid oligomers in neutral phosphate buffer. J. Chromatogr. B: Biomed. Sci. Appl. 1998, 706, 73–82. DOI: 10.1016/S0378-4347(97)00468-4">10.1016/S0378-4347(97)00468-4.
   PubMed Web of Science ®Google Scholar
• Nuyken, O.; Pask, S. D. Ring-Opening Polymerization—An Introductory Review. Polymers 2013, 5, 361–403. DOI: 10.3390/polym5020361.
   Web of Science ®Google Scholar
• Li, H. Advanced Biodegradable Organic Polymers. In Advanced Functional Materials, 1st ed.; Woo, H.-G., Li, H., Eds.; Springer: Berlin, 2011; pp 37–64.
   Google Scholar
• Basko, M. Activated monomer mechanism in the cationic polymerization of L,L-lactide. Pure Appl. Chem. 2012, 84, 2081–2088. DOI: 10.1351/PAC-CON-11-10-19.
   Web of Science ®Google Scholar
• Ikpo, N.; Hoffmann, C.; Dawe, L. N.; Kerton, F. M. Ring-opening polymerization of ε-caprolactone by lithium piperazinyl-aminephenolate complexes: synthesis, characterization and kinetic studies. Dalton Trans. 2012, 41, 6651–6660. DOI: 10.1039/C2DT30276D.
   PubMed Web of Science ®Google Scholar
• Zhao, H.; Nathaniel, G. A.; Merenini, P. C. Enzymatic ring-opening polymerization (ROP) of lactides and lactone in ionic liquids and organic solvents: digging the controlling factors. RSC Adv. 2017, 7, 48639–48648. DOI: 10.1039/C7RA09038B.
   Web of Science ®Google Scholar
• Shiro, K. Enzymatic Ring-Opening Polymerization of Lactones by Lipase Catalyst: Mechanistic Aspects. Macromol. Symp. 2006, 240, 178–185. DOI: 10.1002/masy.200650822">10.1002/masy.200650822.
   Google Scholar
• Hiroshi, U.; Shiro, K. Enzymatic Ring-Opening Polymerization of Lactones Catalyzed by Lipase. Chem. Lett. 1993, 22, 1149–1150. DOI: 10.1246/cl.1993.1149">10.1246/cl.1993.1149.
   Google Scholar
• Lee, J.; Oh, S.; Joo, M. K.; Jeong, B. Solvent-free preparation of caprolactone oligomer microspheres. J. Phys. Chem. Solids, 2008,69, 1596–1599. DOI:https://doi.org/10.1016/j.jpcs.2007.09.016.
   Web of Science ®Google Scholar
• Natarajan, V.; Krithica, N.; Madhan, B.; Sehgal, P. K. Formulation and Evaluation of Quercetin Polycaprolactone Microspheres for the Treatment of Rheumatoid Arthritis. J.Pharm. Sci. 2011,100, 195–205. DOI: 10.1002/jps.22266.
   PubMed Web of Science ®Google Scholar
• Ramesh, D. V. Comparison of oil-in-oil, water-in-oil-in-water and melt encapsulation techniques for the preparation of controlled release B12 Poly(ε-caprolactone) microparticles. Trends Biomater. Artif. Organs, 2009,23, 21–33.
   Google Scholar
• Sastre, R. L.; Blanco, M. D.; Teijón, C.; Olmo, R.; Teijón, J. M. Preparation and characterization of 5-fluorouracil-loaded poly(ϵ-caprolactone) microspheres for drug administration. Drug Dev. Res. 2004,63, 41–53. DOI: 10.1002/ddr.10396.
   Web of Science ®Google Scholar
• Hombreiro-Pérez, M.; Zinutti, C.; Lamprecht, A.; Ubrich, N.; Astier, A.; Hoffman, M.; Bodmeier, R.; Maincent, P. The preparation and evaluation of poly(ϵ-caprolactone) microparticles containing both a lipophilic and a hydrophilic drug. J. Controlled Release, 2000,65, 429–438. DOI: 10.1016/S0168-3659(99)00253-9.
   PubMed Web of Science ®Google Scholar
• Guerra, G. D.; Cristallini, C.; Barbani, N.; Gagliardi, M. Bioresorbable microspheres as devices for the controlled release of paclitaxel. International Journal of Biology and Biomedical Engineering, 2011,5, 121–128.
   Google Scholar
• Shiny, J.; Ramchander, T.; Goverdhan, P.; Habibuddin, M.; Aukunuru, J. V. Development and evaluation of novel biodegradable sustained release microsphere fomulation of paclitaxel intended to treat breast cancer. Int. J. Pharm. Investig. 2013,3, 119–125. DOI: 10.4103/2230-973X.119212.
   PubMedGoogle Scholar
• Wagh, P.; Naik, J. B. Formulation and characterization of ketoprofen embeddd polycaprolactone microspheres using solvent evaporation method. ADMET & DMPK, 2015,3, 141–153. DOI: 10.5599/admet.3.2.167">10.5599/admet.3.2.167.
   Google Scholar
• Guzmán, M.; Molpeceres, J.; García, F.; Aberturas, M. R. Preparation, characterization and in vitro drug release of poly-ε-caprolactone and hydroxypropyl methylcellulose phthalate ketoprofen loaded microspheres. J. Microencapsulation, 1996,13, 25–39. DOI: 10.3109/02652049609006801.
   PubMed Web of Science ®Google Scholar
• Barbosa, J.A.P.; Franco, E. S.; Silva, C.V.N.S.; Bezerra, T. O.; Santana, M.A.N.; Júnior, C.H.R.C.; Silva, T. G.; Santos, N.P.S.; Maia, M.B.S. Poly-ϵ-Caprolactone Microspheres Polymers Containing Usnic Acid: Acute Toxicity and Anti-inflammatory Activity.J. Evidence-based Complementary Altern. Med.2017,2017,1–9. DOI: 10.1155/2017/7392891.
   Google Scholar
• Azouz, L. H.; Dahmoune, F.; Rezgui, F.; G’Sell, C. Full factorial design optimization of anti-inflammatory drug release by PCL–PEG–PCL microspheres. Mater. Sci. Eng. C2016, 58, 412–419. DOI: 10.1016/j.msec.2015.08.058.
   Google Scholar
• Pérez de la Ossa, D. H.; Ligresti, A.; Gil-Alegre, M. E.; Aberturas, M. R.; Molpeceres, J.; Di Marzo, V.; Torres-Suárez, A. I. Poly-ε-caprolactone microspheres as a drug delivery system for cannabinoid administration: Development, characterization and in vitro evaluation of their antitumoral efficacy. J. Controlled Release, 2012,161, 927–932. DOI: 10.1016/j.jconrel.2012.05.003.
   PubMed Web of Science ®Google Scholar
• Dhanaraju, M. D.; Sathyamoorthy, N.; Sundar, V. D.; Suresh, C. Preparation of poly (epsilon-caprolactone) microspheres cotaining etoposide by solvent evaporation method. Asian J. Pharm. Sci. 2010,5, 114–122.
   Google Scholar
• Ghosal, K.; Ghosh, D; Das, S. K. Preparation and evaluation of naringin-loaded polycaprolactone microspheres based oral suspension using Box-Behnken design. J. Mol. Liq. 2018,256, 49–57.DOI: 10.1016/j.molliq.2018.02.024.
   Web of Science ®Google Scholar
• Aberturas, M. R.; Molpeceres, J.; Guzmán, M.; García, F. Development of a new cyclosporine formulation based on poly(caprolactone) microspheres. J.Microencapsulation, 2002,19, 61–72. DOI:10.1080/02652040110055270.
   PubMed Web of Science ®Google Scholar
• Barbato, F.; La Rotonda, M. I.; Maglio, G.; Palumbo, R.; Quaglia, F. Biodegradable microspheres of novel segmented poly(ether-ester-amide)s based on poly(ε-caprolactone) for the delivery of bioactive compounds. Biomaterials, 2001,22, 1371–1378. DOI:10.1016/S0142-9612(00)00291-X.
   PubMed Web of Science ®Google Scholar
• Poletto, F. S.; Jäger, E.; Ré, M. I.; Guterres, S. S.; Pohlman, A. R. Rate-modulating PHBHV/PCL microparticles containing weak acid model drugs. Int. J. Pharm. 2007,345, 70–80. DOI:10.1016/j.ijpharm.2007.05.040.
   PubMed Web of Science ®Google Scholar
• Aydin, O.; Aydin, B.; Tezcaner, A.; Keskin, D. Study on physiochemical structure and in vitro release behaviors of doxycycline-loaded PCL microspheres. J. Appl. Polym. Sci. 2015,132, 1–13. DOI: 10.1002/app.41768">10.1002/app.41768.
   PubMed Web of Science ®Google Scholar
• Amselem, S.; Alving, C. R.; Domb, A. J. Polymeric biodegradable lipospheres™ as vaccine delivery systems. Polym. Adv. Technol. 1992,3, 351–357. DOI: 10.1002/pat.1992.220030611.
   Google Scholar
• Jeong, J.-C.; Lee, J.; Cho, K. Effects of crystalline microstructure on drug release behavior of poly(ε-caprolactone) microspheres. J. Controlled Release, 2003,92, 249–258. DOI: 10.1016/S0168-3659(03)00367-5.
   PubMed Web of Science ®Google Scholar
• Kim, B. K.; Hwang, S. J.; Park, J. B.; Park, H. J. Characteristics of felodipine-located poly(ε-caprolactone) microspheres. J. Microencapsulation, 2005,22, 193–203. DOI: 10.1080/02652040400015346..
   PubMed Web of Science ®Google Scholar
• Benoit, M.-A.; Baras, B.; Gillard, J. Preparation and characterization of protein-loaded poly(ε-caprolactone) microparticles for oral vaccine delivery. Int. J. Pharm. 1999,184, 73–84. DOI: 10.1016/S0378-5173(99)00109-X.
   PubMed Web of Science ®Google Scholar
• Jameela, S. R.; Suma, N.; Jayakrishnan, A. Protein release from poly(ε-caprolactone) microspheres prepared by melt encapsulation and solvent evaporation techniques: A comparative study. J. Biomater. Sci., Polym. Ed. 1997,8, 457–466. DOI: 10.1163/156856297X00380.
   PubMed Web of Science ®Google Scholar
• Krithica, N.; Natarajan, V.; Madhan, B.; Sehgal, P. K.; Mandal, A. B. Type I Collagen Immobilized Poly(caprolactone) Nanofibers: Characterization of Surface Modification and Growth of Fibroblasts. Adv. Eng. Mater. 2012,14, B149–B154. DOI:10.1002/adem.201180035.
   Web of Science ®Google Scholar
• Nguyen, T.-H.; Lee, B.-T. The effect of cross-linking on the microstructure, mechanical properties and biocompatibility of electrospun polycaprolactone–gelatin/PLGA–gelatin/PLGA–chitosan hybrid composite. Sci. Technol. Adv. Mater. 2012,13, 1–11. DOI: 10.1088/1468-6996/13/3/035002">10.1088/1468-6996/13/3/035002.
   Web of Science ®Google Scholar
• Bao, T.-Q.; Franco, R. A.; Lee, B.-T. Preparation and characterization of a novel 3D scaffold from poly(ɛ-caprolactone)/biphasic calcium phosphate hybrid composite microspheres adhesion. Biochem. Eng. J. 2012,64, 76–83. DOI: 10.1016/j.bej.2012.02.005.
   Web of Science ®Google Scholar
• Hayat, M. A. Introduction. In Tumors of the Central Nervous System, 1st ed.; Hayat, M. A., Ed.; Springer: Berlin, 2011; Vol.1, pp 3–8.
   Google Scholar
• Pardridge, W. M. BBB-Genomics: creating new openings for brain-drug targeting. Drug Discovery Today, 2001, 6, 381–383. DOI: 10.1016/S1359-6446(01)01721-4.
   PubMed Web of Science ®Google Scholar
• Ashour, A. E.; Badran, M. M.; Kumar, A.; Rishi, A. K.; Yassin, A. E. Di-Block PLCL and Tri-Block PLCLG Matrix Polymeric Nanoparticles Enhanced the Anticancer Activity of Loaded 5-Fluorouracil. IEEE Trans. Nanobioscience, 2016, 15, 739–747. DOI: 10.1109/TNB.2016.2612340.
   PubMed Web of Science ®Google Scholar
• Karanam, V.; Marslin, G.; Krishnamoorthy, B,; Vijayaraghavan, C.; Siram, K.; Natarajan, T.; Bhaskar, B.; Franklin, G. Poly (ɛ-caprolactone) nanoparticles of carboplatin: Preparation, characterization and in vitro cytotoxicity evaluation in U-87 MG cell lines. Colloids Surf., B, 2015, 130, 48–52. DOI: 10.1016/j.colsurfb.2015.04.005.
   PubMed Web of Science ®Google Scholar
• Xin, H.; Chen, L.; Gu, J.; Ren, X.; Wei, Z.; Luo, J.; Chen, Y.; Jiang, X.; Sha, X.; Fang, X. Enhanced anti-glioblastoma efficacy by PTX-loaded PEGylated poly(ɛ-caprolactone) nanoparticles: In vitro and in vivo evaluation. Int. J. Pharm. 2010, 402,238–247. DOI: 10.1016/j.ijpharm.2010.10.005.
   PubMed Web of Science ®Google Scholar
• Yadav, B.V.N.; Ravichandiran, V.; Kumar, S. S. Preparation and characterization of gemcitabine loaded MPEG-PCL polymeric nanoparticles for improved transportation across blood brain barrier. Int. J. Pharm. Pharm. Sci. 2016, 8, 83–90.
   Google Scholar
• Duvoix, A.; Blasius, R.; Delhalle, S.; Schnekenburger, M.; Morceau, F.; Henry, E.; Dicato, M.; Diederich, M. Chemopreventive and therapeutic effects of curcumin. Cancer Lett. 2005, 223, 181–190. DOI: 10.1016/j.canlet.2004.09.041.
   PubMed Web of Science ®Google Scholar
• Perry, M.-C.; Demeule, M.; Régina, A.; Moumdijan, R.; Béliveau, R. Curcumin inhibits tumor growth and angiogenesis in glioblastoma xenografts. Mol. Nutr. Food Res. 2010, 54, 1192–1201. DOI: 10.1002/mnfr.200900277.
   PubMed Web of Science ®Google Scholar
• Shao, J.; Zheng, D.; Jiang, Z.; Xu, H.; Hu, Y.; Li, X.; Lu, X. Curcumin delivery by methoxy polyethylene glycol–poly(caprolactone) nanoparticles inhibits the growth of C6 glioma cells. Acta Biochim. Biophys. Sin. 2011, 43, 267–274. DOI: 10.1093/abbs/gmr011.
   Google Scholar
• Marslin, G.; Sarmento, B.F.C.C.; Franklin, G.; Martins, J.A.R.; Silva, C.J.R.; Gomes, A. F.C.; Sárria, M. P.; Coutinho, O.M.F.P.; Días, A. C.P. Curcumin Encapsulated into Methoxy Poly(Ethylene Glycol) Poly(ε-Caprolactone) Nanoparticles Increases Cellular Uptake and Neuroprotective Effect in Glioma Cells. Planta Med. 2017, 83, 434–444. DOI: 10.1055/s-0042-112030.
   PubMed Web of Science ®Google Scholar
• Shao, J.; Li, X.; Lu, X.; Jiang, C.; Hu, Y.; Li, Q.; You, Y.; Fu, Z. Enhanced growth inhibition effect of Resveratrol incorporated into biodegradable nanoparticles against glioma cells is mediated by the induction of intracellular reactive oxygen species levels. Colloids Surf., B, 2009, 72, 40–47. DOI:10.1016/j.colsurfb.2009.03.010.
   PubMed Web of Science ®Google Scholar
• Herz, J. LRP: a bright beacon at the blood-brain barrier. J. Clin. Invest. 2003, 112, 1483–1485. DOI:10.1172/JCI200320337.
   PubMed Web of Science ®Google Scholar
• Maletínská, L.; Blakely, E. A.; Bjornstad, K. A.; Deen, D. F.; Knoff, L. J.; Forte, T. M. Human Glioblastoma Cell Lines: Levels of Low-Density Lipoprotein Receptor and Low-Density Lipoprotein Receptor-related Protein. Cancer Res. 2000, 60, 2300–2303.
   PubMed Web of Science ®Google Scholar
• Xin, H.; Jiang, X.; Gu, J.; Sha, X.; Chen, L.; Law, K.; Chen, Y.; Wang, X.; Jiang, Y.; Fang, X. Angiopep-conjugated poly(ethylene glycol)-co-poly(ε-caprolactone) nanoparticles as dual-targeting drug delivery system for brain glioma. Biomaterials, 2011, 32, 4293–4305. DOI:10.1016/j.biomaterials.2011.02.044.
   PubMed Web of Science ®Google Scholar
• Xin, H.; Sha, X.; Jiang, X.; Zhang, W.; Chen, L.; Fang, X. Anti-glioblastoma efficacy and safety of paclitaxel-loading Angiopep-conjugated dual targeting PEG-PCL nanoparticles. Biomaterials, 2012,33, 8167–8176. DOI: 10.1016/j.biomaterials.2012.07.046.
   PubMed Web of Science ®Google Scholar
• Carvalho, C.; Santos, R. X.; Cardoso, S.; Correia, S.; Oliveira, P. J.; Santos, M. S.; Moreira, P. I. Doxorubicin: The Good, the Bad and the Ugly Effect. Curr. Med. Chem. 2009, 16, 3267–3285. DOI:10.2174/092986709788803312.
   PubMed Web of Science ®Google Scholar
• Lu, F.; Pang, Z.; Zhao, J.; Jin, K.; Li, H.; Pang, Q.; Zhang, L.; Pang, Z. Angiopep-2-conjugated poly(ethylene glycol)-co- poly(ε-caprolactone) polymersomes for dual-targeting drug delivery to glioma in rats. Int. J. Nanomedicine, 2017, 12, 2117–2127. DOI: 10.2147/IJN.S123422.
   PubMed Web of Science ®Google Scholar
• Tian, X.-H.; Lin, X.-N.; Wei, F.; Feng, W.; Huang, Z.-C.; Wang, P.; Ren, L.; Diao, Y. Enhanced brain targeting of temozolomide in polysorbate-80 coated polybutylcyanoacrylate nanoparticles. Int. J. Nanomedicine, 2011, 6, 445–452. DOI: 10.2147/IJN.S16570">10.2147/IJN.S16570.
   PubMed Web of Science ®Google Scholar
• Sun, W.; Xie, C.; Wang, H.; Hu, Y. Specific role of polysorbate 80 coating on the targeting of nanoparticles to the brain. Biomaterials, 2004, 25, 3065–3071. DOI:10.1016/j.biomaterials.2003.09.087.
   PubMed Web of Science ®Google Scholar
• Wilson, B.; Samanta, M. K.; Santhi, K.; Kumar, K.P.S.; Paramakrishnan, N.; Suresh, B. Poly(n-butylcyanoacrylate) nanoparticles coated with polysorbate 80 for the targeted delivery of rivastigmine into the brain to treat Alzheimer's disease. Brain Res. 2008, 1200, 159–168. DOI:10.1016/j.brainres.2008.01.039.
   PubMed Web of Science ®Google Scholar
• Wohlfart, S.; Gelperina, S.; Kreuter, J. Transport of drugs across the blood–brain barrier by nanoparticles. J. Controlled Release, 2012, 161, 264–273. DOI: 10.1016/j.jconrel.2011.08.017.
   PubMed Web of Science ®Google Scholar
• Ma, Y.; Zheng, Y.; Zeng, X.; Jiang, L.; Chen, H.; Liu, R.; Huang, L.; Mei, L. Novel docetaxel-loaded nanoparticles based on PCL-Tween 80 copolymer for cancer treatment. Int. J. Nanomedicine, 2011, 6, 2679–2688. DOI: 10.2147/IJN.S25251">10.2147/IJN.S25251.
   PubMed Web of Science ®Google Scholar
• Wang, Y.; Wang, C.; Gong, C.; Wang, Y.; Guo, G.; Luo, F.; Qian, Z. Polysorbate 80 coated poly (ɛ-caprolactone)–poly (ethylene glycol)–poly (ɛ-caprolactone) micelles for paclitaxel delivery. Int. J. Pharm. 2012, 434, 1–8. DOI: 10.1016/j.ijpharm.2012.05.015.
   PubMed Web of Science ®Google Scholar
• Bernardi, A.; Jacques-Silva, M. C.; Delgado-Cañedo, A.; Lenz, G.; Battastini, A.M.O. Nonsteroidal anti-inflammatory drugs inhibit the growth of C6 and U138-MG glioma cell lines. Eur. J. Pharmacol. 2006, 532, 214–222. DOI: 10.1016/j.ejphar.2006.01.008.
   PubMed Web of Science ®Google Scholar
• Bernardi, A.; Frozza, R. L.; Jäger, E.; Figueiró, F.; Bavaresco, L.; Salbego, C.; Pohlmann, A. R.; Guterres, S. S.; Battastini, A.M.O. Selective cytotoxicity of indomethacin and indomethacin ethyl ester-loaded nanocapsules against glioma cell lines: An in vitro study. Eur. J. Pharmacol. 2008, 586, 24–34. DOI: 10.1016/j.ejphar.2008.02.026.
   PubMed Web of Science ®Google Scholar
• Bernardi, A.; Braganhol, E.; Jäger, E.; Figueiró, F.; Edelweiss, M. I.; Pohlmann, A. R.; Guterres, S. S.; Battastini, A.M.O. Indomethacin-loaded nanocapsules treatment reduces in vivo glioblastoma growth in a rat glioma model. Cancer Lett. 2009, 281, 53–63. DOI: 10.1016/j.canlet.2009.02.018.
   PubMed Web of Science ®Google Scholar
• Mintz, A.; Gibo, D. M.; Slagle-Webb, B.; Christensent, N. D.; Debinski, W. IL-13Rα2 is a Glioma-Restricted Receptor for Interleukin-13. Neoplasia, 2002, 4, 388–399. DOI:10.1038/sj.neo.7900234.
   PubMed Web of Science ®Google Scholar
• Gao, H.; Yang, Z.; Zhang, S.; Cao, S.; Shen, S.; Pang, Z.; Jiang, X. Ligand modified nanoparticles increases cell uptake, alters endocytosis and elevates glioma distribution and internalization. Sci. Rep. 2013, 3, 1-8. DOI:10.1038/srep02534.
   Web of Science ®Google Scholar
• Gao, H.; Yang, Z.; Zhang, S.; Cao, S.; Pang, Z.; Yang, X.; Jiang, X. Glioma-homing peptide with a cell-penetrating effect for targeting delivery with enhanced glioma localization, penetration and suppression of glioma growth. J. Controlled Release, 2013, 172, 921–928. DOI: 10.1016/j.jconrel.2013.10.002.
   PubMed Web of Science ®Google Scholar
• Yadavilli, S.; Hwang, E. I.; Packer, R. J.; Nazarian, J. The Role of NG2 Proteoglycan in Glioma. Transl. Oncol. 2016, 9, 57–63. DOI: 10.1016/j.tranon.2015.12.005.
   PubMed Web of Science ®Google Scholar
• Chi, Y.; Zhu, S.; Wang, C.; Zhou, L.; Zhang, L.; Li, Z. Glioma homing peptide-modified PEG-PCL nanoparticles for enhanced anti-glioma therapy. J. Drug Targeting, 2016, 24, 224–232. DOI: 10.3109/1061186X.2015.1070854.
   PubMed Web of Science ®Google Scholar
• El-Kenawi, A. E.; El-Remessy, A. B. Angiogenesis inhibitors in cancer therapy: mechanistic perspective on classification and treatment rationales. Br. J. Pharmacol. 2013, 170, 712–729. DOI: 10.1111/bph.12344.
   PubMed Web of Science ®Google Scholar
• Hoffman, J. A.; Giraudo, E.; Singh, M.; Zhang, L.; Inoue, M.; Porkka, K.; Hanahan, D.; Ruoslahti, E. Progressive vascular changes in a transgenic mouse model of squamous cell carcinoma. Cancer Cell, 2003, 4, 383–391. DOI:10.1016/S1535-6108(03)00273-3.
   PubMed Web of Science ®Google Scholar
• Agemy, L.; Friedmann-Morvinski, D.; Kotamraju, V. R.; Roth, L.; Sugahara, K. N.; Girard, O. M.; Mattrey, R. F.; Verma, I. M.; Ruoslahti, E. Targeted nanoparticle enhanced proapoptotic peptide as potential therapy for glioblastoma. Proc. Natl. Acad. Sci. U.S.A. 2011, 108, 17450–17455. DOI:10.1073/pnas.1114518108.
   PubMed Web of Science ®Google Scholar
• Hu, Q., Gao, X.; Kang, T.; Feng, X.; Jiang, D.; Yifan, T.; Song, Q.; Yao, L.; Jiang, X.; Chen, H.; et al. CGKRK-modified nanoparticles for dual-targeting drug delivery to tumor cells and angiogenic blood vessels. Biomaterials, 2013, 34, 9496–9508. DOI: 10.1016/j.biomaterials.2013.09.001.
   PubMed Web of Science ®Google Scholar
• Wu, X.; Chen, J.; Wu, M.; Zhao, J. X. Aptamers: Active Targeting Ligands for Cancer Diagnosis and Therapy. Theranostics, 2015, 5, 322–344. DOI:10.7150/thno.10257.
   PubMed Web of Science ®Google Scholar
• Bayrac, A. T.; Sefah, K.; Parekh, P.; Bayrac, C.; Gulbakan, B.; Oktem, H. A.; Tan, W. In Vitro Selection of DNA Aptamers to Glioblastoma Multiforme. ACS Chem. Neurosci. 2011, 2, 175–181. DOI: 10.1021/cn100114k.
   PubMed Web of Science ®Google Scholar
• Gao, H.; Qian, J.; Yang, Z.; Pang, Z.; Xi, Z.; Cao, S.; Wang, Y.; Pan, S.; Zhang, S.; Wang, W.; et al. Whole-cell SELEX aptamer-functionalised poly(ethyleneglycol)-poly(ε-caprolactone) nanoparticles for enhanced targeted glioblastoma therapy. Biomaterials, 2012, 33, 6264–6272. DOI: 10.1016/j.biomaterials.2012.05.020.
   PubMed Web of Science ®Google Scholar
• Koren, E.; Torchilin, V. P. Cell-penetrating peptides: breaking through to the other side. Trends Mol. Med. 2012, 18, 385–393. DOI: 10.1016/j.molmed.2012.04.012.
   PubMed Web of Science ®Google Scholar
• He, H.; Ye, J.; Liu, E.; Liang, Q.; Liu, Q.; Yang, V. C. Low molecular weight protamine (LMWP): A nontoxic protamine substitute and an effective cell-penetrating peptide. J. Controlled Release, 2014, 193, 63–73. DOI:10.1016/j.jconrel.2014.05.056.
   PubMed Web of Science ®Google Scholar
• Jiang, T.; Olson, E. S.; Nguyen, Q. T.; Roy, M.; Jennings, P. A.; Tsien, R. Y. Tumor imaging by means of proteolytic activation of cell-penetrating peptides. Proc. Natl. Acad. Sci. U.S.A.2004, 101, 17867–17872. DOI:10.1073/pnas.0408191101.
   PubMed Web of Science ®Google Scholar
• Gu, G.; Xia, H.; Hu, Q.; Liu, Z.; Jiang, M.; Kang, T.; Miao, D.; Tu, Y.; Pang, Z.; Song, Q.; et al. PEG-co-PCL nanoparticles modified with MMP-2/9 activatable low molecular weight protamine for enhanced targeted glioblastoma therapy. Biomaterials, 2013, 34, 196–208. DOI: 10.1016/j.biomaterials.2012.09.044.
   PubMed Web of Science ®Google Scholar
• Agarwal, S.; Sane, R.; Oberoi, R.; Ohlfest, J. R.; Elmguist, W. F. Delivery of Molecularly Targeted Therapy to Malignant Glioma, a Disease of the Whole Brain. Expert Rev. Mol. Med. 2011, 13, 1–27. DOI: 10.1017/S1462399411001888">10.1017/S1462399411001888.
   Web of Science ®Google Scholar
• Huile, G.; Shuaiqi, P.; Zhi, Y.; Shijie, C.; Chen, C.; Xinguo, J.; Shun, S.; Zhiqing, P.; Yu, H. A cascade targeting strategy for brain neuroglial cells employing nanoparticles modified with angiopep-2 peptide and EGFP-EGF1 protein. Biomaterials, 2011, 32, 8669–8675. DOI: 10.1016/j.biomaterials.2011.07.069.
   PubMed Web of Science ®Google Scholar
• Gao H.; Qian, J.; Cao, S.; Yang, Z.; Pang, Z.; Pan, S.; Fan, L.; Xi, Z.; Jiang, X.; Zhang, Q. Precise glioma targeting of and penetration by aptamer and peptide dual-functioned nanoparticles. Biomaterials, 2012, 33, 5115–5123. DOI:10.1016/j.biomaterials.2012.03.058.
   PubMed Web of Science ®Google Scholar
• Gao, H.; Zhang, S.; Cao, S.; Yang, Z.; Pang, Z.; Jiang, X. Angiopep-2 and Activatable Cell-Penetrating Peptide Dual-Functionalized Nanoparticles for Systemic Glioma-Targeting Delivery. Mol. Pharmaceutics, 2014, 11, 2755–2763. DOI:10.1021/mp500113p.
   PubMed Web of Science ®Google Scholar
• Djupesland, P. G.; Mahmoud, R. A.; Messina, J. C. Accessing the brain: the nose may know the way. J. Cereb. Blood Flow Metab. 2013, 33, 793–794. DOI:10.1038/jcbfm.2013.41.
   PubMed Web of Science ®Google Scholar
• Alex, A. T.; Joseph, A.; Shavi, G.; Rao, J. V.; Udupa, N. Development and evaluation of carboplatin-loaded PCL nanoparticles for intranasal delivery. Drug Delivery, 2016, 23, 2144–2153. DOI: 10.3109/10717544.2014.948643.
   PubMed Web of Science ®Google Scholar
• Merkus, F.W.H.M.; van den Berg, M. P. Can Nasal Drug Delivery Bypass the Blood-Brain Barrier? Drugs R D, 2007, 8, 133–144. DOI: 10.2165/00126839-200708030-00001.
   PubMedGoogle Scholar
• Kanazawa, T.; Taki, H.; Tanaka, K.; Takashima, Y.; Okada, H. Cell-Penetrating Peptide-Modified Block Copolymer Micelles Promote Direct Brain Delivery via Intranasal Administration. Pharm. Res. 2011, 28, 2130–2139. DOI: 10.1007/s11095-011-0440-7.
   PubMed Web of Science ®Google Scholar
• Taki, H.; Kanazawa, T.; Akiyama, F.; Takashima, Y.; Okada, H. Intranasal Delivery of Camptothecin-Loaded Tat-Modified Nanomicells for Treatment of Intracranial Brain Tumors. Pharmaceuticals, 2012, 5, 1092–1103. DOI: 10.3390/ph5101092.
   Google Scholar
• Guo, W.; Chen, W.; Yu, W.; Huang, W.; Deng, W. Small interfering RNA-based molecular therapy of cancers. Chin. J. Cancer, 2013, 32, 488–493. DOI: 10.5732/cjc.012.10280.
   PubMedGoogle Scholar
• Kanazawa, T.; Akiyama, F.; Kakizaki, S.; Takashima, Y.; Seta, Y. Delivery of siRNA to the brain using a combination of nose-to-brain delivery and cell-penetrating peptide-modified nano-micelles. Biomaterials, 2013, 34, 9220–9226. DOI: 10.1016/j.biomaterials.2013.08.036.
   PubMed Web of Science ®Google Scholar
• Leng, Q.; Mixson, A. J. Small interfering RNA targeting Raf-1 inhibits tumor growth in vitro and in vivo. Cancer Gene Ther. 2005, 12, 682–690. DOI: 10.1038/sj.cgt.7700831.
   PubMed Web of Science ®Google Scholar
• Kanazawa, T.; Morisaki, K.; Suzuki, S.; Takashima, Y. Prolongation of Life in Rats with Malignant Glioma by Intranasal siRNA/Drug Codelivery to the Brain with Cell-Penetrating Peptide-Modified Micelles. Mol. Pharmaceutics, 2014, 11, 1471–1478. DOI: 10.1021/mp400644e.
   PubMed Web of Science ®Google Scholar
• Wolinsky, J. B.; Colson, Y. L.; Grinstaff, M. W. Local drug delivery strategies for cancer treatment: Gels, nanoparticles, polymeric films, rods, and wafers. J. Controlled Release, 2012, 159, 14–26. DOI: 10.1016/j.jconrel.2011.11.031.
   PubMed Web of Science ®Google Scholar
• Mehta, A. M.; Sonabend, A. M.; Bruce, J. N. Convection-Enhanced Delivery. Neurotherapeutics, 2017, 14, 358–371. DOI: 10.1007/s13311-017-0520-4.
   PubMed Web of Science ®Google Scholar
• Çırpanlı, Y.; Allard, E.; Passirani, C.; Bilensoy, E.; Lemaire, L.; Çalış S.; Benoit, J.-P. Antitumoral activity of camptothecin-loaded nanoparticles in 9L rat glioma model. Int. J. Pharm. 2011, 403, 201–206. DOI: 10.1016/j.ijpharm.2010.10.015.
   PubMed Web of Science ®Google Scholar
• Ferlay, J.; Soerjomataram, I.; Dikshit, R.; Eser, S.; Mathers, C.; Rebelo, M; Parkin, D. M.; Forman, D.; Bray, F. Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012. Int. J. Cancer, 2015, 136, E359–E386. DOI: 10.1002/ijc.29210.
   PubMed Web of Science ®Google Scholar
• Cabeza, L.; Ortiz, R.; Prados, J.; Delgado, A. V.; Martín-Villena, M. J.; Clares, B.; Perazzoli, G.; Entrena, J. M.; Melguizo, C.; Arias, J. L. Improved antitumor activity and reduced toxicity of doxorubicin encapsulated in poly(ε-caprolactone) nanoparticles in lung and breast cancer treatment: An in vitro and in vivo study. Eur. J. Pharm. Sci. 2017, 102, 24–34. DOI:10.1016/j.ejps.2017.02.026.
   PubMed Web of Science ®Google Scholar
• Shavi, G. V.; Nayak, U. Y.; Maliyakkal, N.; Deshpande, P. B.; Raghavendra, R.; Kumar, A. R.; Reddya, M. S.; Udupa, N.; Shrawan, B. Nanomedicine of anastrozole for breast cancer: Physicochemical evaluation, in vitro cytotoxicity on BT-549 and MCF-7 cell lines and preclinical study on rat model. Life Sci. 2015, 141, 143–155. DOI: 10.1016/j.lfs.2015.09.021.
   PubMed Web of Science ®Google Scholar
• López-Gasco, P.; Iglesias, I.; Benedí, J.; Lozano, R.; Teijón, J. M.; Blanco, M. D. Paclitaxel-loaded polyester nanoparticles prepared by spray-drying technology: in vitro bioactivity evaluation. J. Microencapsulation, 2011, 28, 417–429. DOI: 10.3109/02652048.2011.576785.
   PubMed Web of Science ®Google Scholar
• Gelderblom, H.; Verweij, J.; Nooter, K.; Sparreboom, A. Cremophor EL: the drawbacks and advantages of vehicle selection for drug fomulation. Eur. J. Cancer, 2001, 37, 1590–1598. DOI: 10.1016/S0959-8049(01)00171-X.
   PubMed Web of Science ®Google Scholar
• Forrest, M. L.; Yáñez, J. A.; Remsberg, C. M.; Ohgami, Y.; Kwon, G. S.; Davies, N. M. Paclitaxel Prodrugs with Sustained Release and High Solubility in Poly(ethylene glycol)-b-poly(ε-caprolactone) Micelle Nanocarriers: Pharmacokinetic Disposition, Tolerability, and Cytotoxicity. Pharm. Res. 2008, 25, 194–206. DOI: 10.1007/s11095-007-9451-9.
   PubMed Web of Science ®Google Scholar
• Wang, C.; Wang, Y.; Wang, Y.; Fan, M.; Luo, F.; Qian, Z. Characterization, pharmacokinetics and disposition of novel nanoscale preparations of paclitaxel. Int. J. Pharm. 2011, 414, 251–259. DOI: 10.1016/j.ijpharm.2011.05.014.
   PubMed Web of Science ®Google Scholar
• Lin, Y.; Shi, R.; Wang, X.; Shen, H.-M. Luteolin, a Flavonoid with Potential for Cancer Prevention and Therapy. Curr. Cancer Drug Targets, 2008, 8, 634–646. DOI: 10.2174/156800908786241050.
   PubMed Web of Science ®Google Scholar
• Qiu, J.-F.; Gao, X.; Wang, B.-L.; Wei, X.-W.; Gou, M.-L.; Men, K.; Liu, X.-Y.; Guo, G.; Qian, Z.-Y.; Huang, M.-J. Preparation and characterization of monomethoxy poly(ethylene glycol)-poly(ε-caprolactone) micelles for the solubilization and in vivo delivery of luteolin. Int. J. Nanomedicine, 2013, 8, 3061–3069. DOI: 10.2147/IJN.S45062">10.2147/IJN.S45062.
   PubMed Web of Science ®Google Scholar
• Qazi, A.; Pal, J.; Maitah, M.; Fulciniti, M.; Pelluru, D.; Nanjappa, P.; Lee, S.; Batchu, R. B.; Prasad, M.; Bryant, C. S.; et al. Anticancer Activity of a Broccoli Derivative, Sulforaphane, in Barrett Adenocarcinoma: Potential Use in Chemoprevention and as Adjuvant in Chemotherapy. Transl. Oncol. 2010, 3, 389–399. DOI: 10.1593/tlo.10235.
   PubMed Web of Science ®Google Scholar
• Clarke, J. D.; Dashwood, R. H.; Ho, E. Multi-targeted prevention of cancer by sulforaphane. Cancer Lett. 2008, 269, 291–304. DOI: 10.1016/j.canlet.2008.04.018.
   PubMed Web of Science ®Google Scholar
• Danafar, H.; Sharafi, A.; Manjili, H. K.; Andalib, S. Sulforaphane delivery using mPEG–PCL co-polymer nanoparticles to breast cancer cells. Pharm. Dev. Technol. 2017, 22, 642–651. DOI: 10.3109/10837450.2016.1146296.
   PubMed Web of Science ®Google Scholar
• McLaughlin, J. L. Paw Paw and Cancer: Annonaceous Acetogenins from Discovery to Commercial Products. J. Nat. Prod. 2008, 71, 1311–1321. DOI: 10.1021/np800191t.
   PubMed Web of Science ®Google Scholar
• Hong, J.; Li, Y.; Li, Y.; Xiao, Y.; Kuang, H.; Wang, X. Annonaceous acetogenins nanosuspensions stabilized by PCL-PEG block polymer: significantly improved antitumor efficacy. Int. J. Nanomedicine, 2016, 11, 3239–3253. DOI: 10.2147/IJN.S108143.
   PubMed Web of Science ®Google Scholar
• Eatemadi, A.; Darabi, M.; Afraidooni, L.; Zarghami, N.; Daraee, H.; Eskandari, L.; Mellatyar, H.; Akbarzadeh, A. Comparison, synthesis and evaluation of anticancer drug-loaded polymeric nanoparticles on breast cancer cell lines. Artif. Cells, Nanomed., Biotechnol. 2016, 44, 1008–1017. DOI: 10.3109/21691401.2015.1008510.
   PubMed Web of Science ®Google Scholar
• Khoo, B. Y.; Chua, S. L.; Balaram, P. Apoptotic Effects of Chrysin in Human Cancer Cell Lines. Int. J. Mol. Sci. 2010, 11, 2188–2199. DOI: 10.3390/ijms11052188.
   PubMed Web of Science ®Google Scholar
• Eatemadi, A.; Daraee, H.; Aiyelabegan, H. T.; Negahdari, B.; Rajeian, B.; Zarghami, N. Synthesis and Characterization of Chrysin-loaded PCL-PEG-PCL nanoparticle and its effect on breast cancer cell line. Biomed. Pharmacother. 2016, 84, 1915–1922. DOI: 10.1016/j.biopha.2016.10.095.
   PubMed Web of Science ®Google Scholar
• Ungaro, F.; Conte, C.; Ostacolo, L.; Maglio, G.; Barbieri, A.; Arra, C.; Misso, G.; Abbruzzese, A.; Caraglia, M.; Quaglia, F. Core-shell biodegradable nanoassemblies for the passive targeting of docetaxel: features, antiproliferative activity and in vivo toxicity. Nanomedicine, 2012, 8, 637–646. DOI:10.1016/j.nano.2011.08.012.
   PubMed Web of Science ®Google Scholar
• Cuong, N.-V.; Hsieh, M.-F.; Chen, Y.-T.; Liau, I. Synthesis and characterization of PEG–PCL–PEG triblock copolymers as carriers of doxorubicin for the treatment of breast cancer. J. Appl. Polym. Sci. 2010, 117, 3694–3703. DOI: 10.1002/app.32266">10.1002/app.32266.
   Web of Science ®Google Scholar
• Cuong, N.-V.; Chen, Y.-T.; Hsieh, M.-F. Doxorubicin-loaded micelles of Y-shaped PEG-(PCL)2 against drug-resistant breast cancer cells. Biomed.Eng. Appl. Basis Commun. 2013, 25,1–10. DOI: 10.4015/S1016237213400097">10.4015/S1016237213400097.
   Google Scholar
• Kabanov, A. V.; Batrakova, E. V.; Alakhov, V. Y. Pluronic® block copolymers for overcoming drug resistance in cancer. Adv. Drug Delivery Rev. 2002, 54, 759–779. DOI: 10.1016/S0169-409X(02)00047-9.
   PubMed Web of Science ®Google Scholar
• Batrakova, E. V.; Kabanov, A. V. Pluronic block copolymers: Evolution of drug delivery concept from inert nanocarriers to biological response modifiers. J. Controlled Release, 2008, 130, 98–106. DOI:10.1016/j.jconrel.2008.04.013.
   PubMed Web of Science ®Google Scholar
• Mei, L.; Zhang, Y.; Zheng, Y.; Tian, G.; Song, C.; Yang, D.; Chen, H.; Sun, H.; Tian, Y.; Liu, K.; et al. A Novel Docetaxel-Loaded Poly (ε-Caprolactone)/Pluronic F68 Nanoparticle Overcoming Multidrug Resistance for Breast Cancer Treatment. Nanoscale Res. Lett. 2009, 4, 1530–1539. DOI: 10.1007/s11671-009-9431-6.
   PubMed Web of Science ®Google Scholar
• Zhang, Y.; Tang, L.; Sun, L.; Bao, J.; Song, C.; Huang, L.; Liu, K.; Tian, Y.; Tian, G.; Li, Z.; et al. Tang A novel paclitaxel-loaded poly(ε-caprolactone)/Poloxamer 188 blend nanoparticle overcoming multidrug resistance for cancer treatment. Acta Biomater. 2010, 6, 2045–2052. DOI: 10.1016/j.actbio.2009.11.035.
   PubMed Web of Science ®Google Scholar
• Varan, C.; Bilensoy, E. Development of implantable hydroxypropyl-β-cyclodextrin coated polycaprolactone nanoparticles for the controlled delivery of docetaxel to solid tumors. J. Inclusion Phenom. Macrocyclic Chem. 2014, 80, 9–15.DOI: 10.1007/s10847-014-0422-6.
   Web of Science ®Google Scholar
• Chen, C.-H.; Cuong, N. V.; Chen, Y. T.; So, R. C.; Liau, I.; Hsieh, M. F. Overcoming Multidrug Resistance of Breast Cancer Cells by the Micellar Doxorubicin Nanoparticles of mPEG-PCL-Graft-Cellulose. J. Nanosci. Nanotechnol. 2011, 11, 53–60. DOI: 10.1166/jnn.2011.3102.
   PubMed Web of Science ®Google Scholar
• Bernabeu, E.; Helguera, G.; Legaspi, M. J.; González, L.; Hocht, C.; Taira, C.; Chiappetta, D. A. Paclitaxel-loaded PCL–TPGS nanoparticles: In vitro and in vivo performance compared with Abraxane®. Colloids Surf., B, 2014, 113, 43–50. DOI: 10.1016/j.colsurfb.2013.07.036.
   PubMed Web of Science ®Google Scholar
• Bernabeu, E.; Gonzalez, L.; Legaspi, M. J.; Moretton, M. A.; Chiappetta, D. A. Paclitaxel-Loaded TPGS-b-PCL Nanoparticles: In Vitro Cytotoxicity and Cellular Uptake in MCF-7 and MDA-MB-231 Cells versus mPEG-b-PCL Nanoparticles and Abraxane®. J. Nanosci. Nanotechnol. 2016, 16, 160–170. DOI: 10.1166/jnn.2016.10739.
   PubMed Web of Science ®Google Scholar
• Ye, L.; Gao, Z.; Zhou, Y.; Yin, X.; Zhang, X.; Zhang, A.; Feng, Z. A pH-sensitive binary drug delivery system based on poly(caprolactone)–heparin conjugates. J. Biomed. Mater. Res., Part A, 2014, 102, 880–889. DOI: 10.1002/jbm.a.34735.
   PubMed Web of Science ®Google Scholar
• Zhang, L.; He, Y.; Ma, G.; Song, C.; Sun, H. Paclitaxel-loaded polymeric micelles based on poly(ɛ-caprolactone)-poly(ethylene glycol)-poly(ɛ-caprolactone) triblock copolymers: in vitro and in vivo evaluation. Nanomedicine, 2012, 8, 925–934. DOI:10.1016/j.nano.2011.11.005.
   PubMed Web of Science ®Google Scholar
• Zhang, L.; Chen, Z.; Wang, H.; Wu, S.; Zhao, K.; Sun, H.; Kong, D.; Wang, C.; Leng, X.; Zhu, D. Preparation and evaluation of PCL-PEG-PCL polymeric nanoparticles for doxorubicin delivery against breast cancer. RSC Adv. 2016, 6, 54727–54737. DOI: 10.1039/C6RA04687H.
   Web of Science ®Google Scholar
• Balendiran, G. K.; Dabur, R.; Fraser, D. The role of glutathione in cancer. Cell Biochem. Funct. 2004, 22, 343–352. DOI: 10.1002/cbf.1149.
   PubMed Web of Science ®Google Scholar
• Wang, Y.-C.; Wang, F.; Sun, T.-M.; Wang, J. Redox-Responsive Nanoparticles from the Single Disulfide Bond-Bridged Block Copolymer as Drug Carriers for Overcoming Multidrug Resistance in Cancer Cells. Bioconjugate Chem. 2011, 22, 1939–1945. DOI: 10.1021/bc200139n.
   PubMed Web of Science ®Google Scholar
• Yin, Q.; Shen, J.; Zhang, Z.; Yu, H.; Chen, L.; Gu, W.; Li, Y. Multifunctional Nanoparticles Improve Therapeutic Effect for Breast Cancer by Simultaneously Antagonizing Multiple Mechanisms of Multidrug Resistance. Biomacromolecules, 2013, 14, 2242–2252. DOI: 10.1021/bm400378x.
   PubMed Web of Science ®Google Scholar
• Wu, Y.; Zhang, Y.; Zhang, W.; Sun, C.; Wu, J.; Tang, J. Reversing of multidrug resistance breast cancer by co-delivery of P-gp siRNA and doxorubicin via folic acid-modified core-shell nanomicelles. Colloids Surf., B, 2016, 138, 60–69. DOI: 10.1016/j.colsurfb.2015.11.041.
   PubMed Web of Science ®Google Scholar
• Masuda, H; Zhang, D.; Bartholomeusz, C.; Doihara, H.; Hortobagyi, G. N.; Ueno, N. T. Role of Epidermal Growth Factor Receptor in Breast Cancer. Breast Cancer Res. Treat. 2012, 136, 331–345. DOI: 10.1007/s10549-012-2289-9.
   PubMed Web of Science ®Google Scholar
• Milane, L.; Duan, Z.; Amiji, M. Development of EGFR-Targeted Polymer Blend Nanocarriers for Combination Paclitaxel/Lonidamine Delivery To Treat Multi-Drug Resistance in Human Breast and Ovarian Tumor Cells. Mol. Pharmaceutics2011,8, 185–203. DOI: 10.1021/mp1002653.
   PubMed Web of Science ®Google Scholar
• Milane, L.; Duan, Z.; Amiji, M. Therapeutic Efficacy and Safety of Paclitaxel/Lonidamine Loaded EGFR-Targeted Nanoparticles for the Treatment of Multi-Drug Resistant Cancer. PLoS One, 2011, 6, 1–11. DOI: 10.1371/journal.pone.0024075">10.1371/journal.pone.0024075.
   Web of Science ®Google Scholar
• Wang, Y.; Chen, L.; Tan, L.; Zhao, Q.; Luo, F.; Wei, Y.; Qian, Z. PEG–PCL based micelle hydrogels as oral docetaxel delivery systems for breast cancer therapy. Biomaterials, 2014, 35, 6972–6985. DOI: 10.1016/j.biomaterials.2014.04.099.
   PubMed Web of Science ®Google Scholar
• Osbild, S.; Brault, L.; Battaglia, E.; Bragel, D. Resistance to Cisplatin and Adriamycin is Associated with the Inhibition of Glutathione Efflux in MCF-7-derived cells. Anticancer Res. 2006, 26, 3595–3600.
   PubMed Web of Science ®Google Scholar
• Surnar, B.; Sharma, K.; Jayakannan, M. Core-shell polymer nanoparticles for prevention of GSH drug detoxification and cisplatin delivery to breast cancer cells. Nanoscale, 2015 , 7, 17964–17979. DOI: 10.1039/C5NR04963F.
   PubMed Web of Science ®Google Scholar
• He, X.; Li, L.; Su, H.; Zhou, D.; Song, H.; Wang, L.; Jiang, X. Poly(ethylene glycol)-block-poly(ε-caprolactone)–and phospholipid-based stealth nanoparticles with enhanced therapeutic efficacy on murine breast cancer by improved intracellular drug delivery. Int. J. Nanomedicine, 2015, 10, 1791–1804. DOI: 10.2147/IJN.S75186">10.2147/IJN.S75186.
   PubMed Web of Science ®Google Scholar
• Zhang, L.; Zhu, D.; Dong, X.; Sun, H.; Song, C.; Wang, C.; Kong, D. Folate-modified lipid–polymer hybrid nanoparticles for targeted paclitaxel delivery. Int. J. Nanomedicine, 2015, 10, 2101–2114. DOI: 10.2147/IJN.S77667">10.2147/IJN.S77667.
   PubMed Web of Science ®Google Scholar
• Chen, D.; Cui, Q. C.; Yang, H.; Dou, Q. P. Disulfiram, a Clinically Used Anti-Alcoholism Drug and Copper-Binding Agent, Induces Apoptotic Cell Death in Breast Cancer Cultures and Xenografts via Inhibition of the Proteasome Activity. Cancer Res. 2006, 66, 10425–10433. DOI:10.1158/0008-5472.
   PubMed Web of Science ®Google Scholar
• Song, W.; Tang, Z.; Lei, T.; Wen, X.; Wang, G.; Zhang, D.; Deng, M.; Tang, X.; Chen, X. Stable loading and delivery of disulfiram with mPEG-PLGA/PCL mixed nanoparticles for tumor therapy. Nanomedicine, 2016, 12, 377–386. DOI: 10.1016/j.nano.2015.10.022.
   PubMed Web of Science ®Google Scholar
• Jadia, R.; Scandore, C.; Rai, P. Nanoparticles for Effective Combination Therapy of Cancer. Int. J. Nanotechnol. Nanomed. 2016, 1, 1–27.
   Google Scholar
• Sun, H.-P, Su, J.-H.; Meng, Q.,-S.; Yin, Q.; Zhang, Z.-W.; Yu, H.-J.; Zhang, P.-C.; Wang, S.-L.; Li, Y.-P. Silibinin and indocyanine green-loaded nanoparticles inhibit the growth and metastasis of mammalian breast cancer cells in vitro. Acta Pharmacol Sin. 2016, 37, 941–949. DOI: 10.1038/aps.2016.20.
   PubMed Web of Science ®Google Scholar
• Lin, Y.-J.; Liu, Y.-S.; Yeh, H.-H.; Chen, T.-L.; Wang, L.-F. Self-assembled poly(ε-caprolactone)-g-chondroitin sulfate copolymers as an intracellular doxorubicin delivery carrier against lung cancer cells. Int. J. Nanomedicine, 2012, 7, 4169–4183. DOI: 10.2147/IJN.S33602">10.2147/IJN.S33602.
   PubMed Web of Science ®Google Scholar
• Jiang, L.; Li, X.; Liu, L.; Zhang, Q. Thiolated chitosan-modified PLA-PCL-TPGS nanoparticles for oral chemotherapy of lung cancer. Nanoscale Res. Lett. 2013, 8, 1–11. DOI: 10.1186/1556-276X-8-66">10.1186/1556-276X-8-66.
   PubMed Web of Science ®Google Scholar
• Garg, A.; Patel, V.; Sharma, R.; Jain, A.; Yadav, A. K. Heparin-appended polycaprolactone core/corona nanoparticles for site specific delivery of 5-fluorouracil. Artif. Cells, Nanomed., Biotechnol. 2017, 45, 1146–1155. DOI:10.1080/21691401.2016.1203793.
   PubMed Web of Science ®Google Scholar
• Xu, H.; Hou, Z.; Zhang, H.; Kong, H.; Li, X.; Wang, H.; Xie, W. An efficient Trojan delivery of tetrandrine by poly(N-vinylpyrrolidone)-block-poly(ε-caprolactone) (PVP-b-PCL) nanoparticles shows enhanced apoptotic induction of lung cancer cells and inhibition of its migration and invasion. Int. J. Nanomedicine, 2014, 9, 231–242. DOI: 10.2147/IJN.S55541">10.2147/IJN.S55541.
   PubMed Web of Science ®Google Scholar
• Yin, H.-T.; Zhang, D.-G.; Wu, X.-L., Huang, X.-E.; Chen, G. In vivo Evaluation of Curcumin-loaded Nanoparticles in an A549 Xenograft Mice Model. Asian Pac. J. Cancer Prev. 2013, 14, 409–412. DOI: 10.7314/APJCP.2013.14.1.409.
   PubMed Web of Science ®Google Scholar
• Yin, H.; Zhang, H.; Liu, B. Superior anticancer efficacy of curcumin-loaded nanoparticles against lung cancer. Acta Biochim. Biophys. Sin. 2013, 45, 634–640. DOI: 10.1093/abbs/gmt063.
   Google Scholar
• Gong, C.; Deng, S.; Wu, Q.; Xiang, M.; Wei, X.; Li, L.; Gao, X.; Wang, B.; Sun, L.; Chen, Y.; et al. Improving antiangiogenesis and anti-tumor activity of curcumin by biodegradable polymeric micelles. Biomaterials, 2013, 34, 1413–1432. DOI:10.1016/j.biomaterials.2012.10.068.
   PubMed Web of Science ®Google Scholar
• Wen, C.; Zhou, Y.; Zhou, C.; Zhang, Y.; Hu, X.; Li, J.; Yin, H. Enhanced Radiosensitization Effect of Curcumin Delivered by PVP-PCL Nanoparticle in Lung Cancer. J. Nanomater. 2017, 2017, 1–8. DOI:10.1155/2017/9625909.
   Web of Science ®Google Scholar
• Yang, Q.; Liao, J.; Deng, X.; Liang, J.; Long, C.; Xie, C.; Chen, X.; Zhang, L.; Sun, J.; Peng, J.; et al. Anti-Tumor Activity and Safety Evaluation of Fisetin-Loaded Methoxy Poly(ethylene glycol)-Poly(ε-Caprolactone) Nanoparticles. J. Biomed. Nanotechnol. 2014, 10, 580–591. DOI: 10.1166/jbn.2014.1746.
   PubMed Web of Science ®Google Scholar
• Wang, B.-L.; Shen, Y.-M.; Zhang, Q.-W.; Li, Y.-L.; Luo, M.; Liu, Z.; Li, Y.; Qian, Z.-Y.; Gao, X.; Shi, H.-S. Codelivery of curcumin and doxorubicin by MPEG-PCL results in improved efficacy of systemically administered chemotherapy in mice with lung cancer. Int. J. Nanomedicine, 2013, 8, 3521–3531. DOI: 10.2147/IJN.S45250">10.2147/IJN.S45250.
   PubMedGoogle Scholar
• Arora, S.; Singh, S.; Piazza, G. A.; Contreras, C. M.; Panyam, J.; Singh, A. P. Honokiol: A Novel Natural Agent for Cancer Prevention and Therapy. Curr. Mol. Med. 2012, 12, 1244–1252. DOI: 10.2174/156652412803833508.
   PubMed Web of Science ®Google Scholar
• Dong, P.; Wang, X.; Gu, Y.; Wang, Y.; Wang, Y.; Gong, C.; Luo, F.; Guo, G.; Zhao, X.; Wei, Y.; et al. Self-assembled biodegradable micelles based on star-shaped PCL-b-PEG copolymers for chemotherapeutic drug delivery. Colloids Surf., A, 2010, 358, 128–134. DOI: 10.1016/j.colsurfa.2010.01.037.
   Web of Science ®Google Scholar
• Li, R.; Wu, W.; Liu, Q.; Wu, P.; Xie, L.; Zhu, Z.; Yang, M.; Qian, X.; Ding, Y.; Yu, L. Intelligently Targeted Drug Delivery and Enhanced Antitumor Effect by Gelatinase-Responsive Nanoparticles. PLoS One, 2013, 8, 1–11. DOI: 10.1371/journal.pone.0069643">10.1371/journal.pone.0069643.
   Web of Science ®Google Scholar
• Askari, S.; Salehi, R.; Zarghami, N.; Akbarzadeh, A.; Rahmati-Yamchi, M. The anticancer effects of biodegradable nanomagnetic dual natural components on the leptin gene expression in lung cancer. Artif. Cells, Nanomed., Biotechnol. 2016, 44, 1753–1763. DOI: 10.3109/21691401.2015.1101000.
   PubMed Web of Science ®Google Scholar
• Mandal, B.; Mittal, N. K.; Balabathula, P.; Thoma, L. A.; Wood, G. C. Development and in vitro evaluation of core–shell type lipid–polymer hybrid nanoparticles for the delivery of erlotinib in non-small cell lung cancer. Eur. J. Pharm. Sci. 2016, 81, 162–171. DOI: 10.1016/j.ejps.2015.10.021.
   PubMed Web of Science ®Google Scholar
• Gao, H.; Zhang, Q.; Yang, Y.; Jiang, X.; He, Q. Tumor homing cell penetrating peptide decorated nanoparticles used for enhancing tumor targeting delivery and therapy. Int. J. Pharm. 2015, 478, 240–250. DOI:10.1016/j.ijpharm.2014.11.029.
   PubMed Web of Science ®Google Scholar
• Gou, M.-L.; Zheng, X.-L.; Men, K.; Zhang, J.; Zheng, L.; Wang, X.-H.; Luo, F.; Zhao, Y.-L.; Zhao, X.; et al. Poly(ε-caprolactone)/Poly(ethylene glycol)/Poly(ε-caprolactone) Nanoparticles: Preparation, Characterization, and Application in Doxorubicin Delivery. J. Phys. Chem B, 2009, 113, 12928–12933. DOI: 10.1021/jp905781g.
   PubMed Web of Science ®Google Scholar
• Li, R.; Li, X.; Xie, L.; Ding, D.; Hu, Y.; Qian, X.; Yu, L.; Ding, Y.; Jiang, X.; Liu, B. Preparation and evaluation of PEG–PCL nanoparticles for local tetradrine delivery. Int. J. Pharm. 2009, 379, 158–166. DOI: 10.1016/j.ijpharm.2009.06.007.
   PubMed Web of Science ®Google Scholar
• Gou, M.; Men, K.; Shi, H.; Xiang, M.; Zhang, J.; Song, J.; Long, J.; Wan, Y.; Luo, F.; Zhao, X.; et al. Curcumin-loaded biodegradable polymeric micelles for colon cancer therapy in vitro and in vivo. Nanoscale, 2011, 3, 1558–1567. DOI: 10.1039/c0nr00758g.
   PubMed Web of Science ®Google Scholar
• Li, X.; Zhen, D.; Lu, X.; Xu, H.; Shao, Y.; Xue, Q.; Hu, Y.; Liu, B.; Sun, W. Enhanced cytotoxicity and activation of ROS-dependent c-Jun NH2-terminal kinase and caspase-3 by low doses of tetrandrine-loaded nanoparticles in Lovo cells – A possible Trojan strategy against cancer. Eur. J. Pharm. Biopharm. 2010, 75, 334–340. DOI: 10.1016/j.ejpb.2010.04.016.
   PubMed Web of Science ®Google Scholar
• Li, R.; Xie, L.; Zhu, Z.; Liu, Q.; Hu, Y.; Jiang, X.; Yu, L.; Qian, X.; Guo, W.; Ding, Y.; et al. Reversion of pH-Induced Physiological Drug Resistance: A Novel Function of Copolymeric Nanoparticles. PLoS One, 2011, 6, 1–13. DOI: 10.1371/journal.pone.0024172">10.1371/journal.pone.0024172.
   Google Scholar
• Ortiz, R.; Prados, J.; Melguizo, C.; Arias, J. L.; Ruiz, M. A.; Alvarez, P. J.; Caba, O.; Lungue, R.; Segura, A.; Aránega, A. 5-Fluorouracil-loaded poly (ε-caprolactone) nanoparticles combined with phage E gene therapy as a new strategy against colon cancer. Int. J. Nanomed. 2012, 7, 95–107. DOI: 10.2147/IJN.S26401">10.2147/IJN.S26401.
   PubMed Web of Science ®Google Scholar
• Badran, M. M.; Mady, M. M.; Ghannam, M. M.; Shakeel, F. Preparation and characterization of polymeric nanoparticles surface modified with chitosan for target treatment of colorectal cancer. Int. J. Biol. Macromol. 2017, 95, 643–649. DOI: 10.1016/j.ijbiomac.2016.11.098.
   PubMed Web of Science ®Google Scholar
• Li, C.-Y.; Wang, E.-Q., Cheng, Y.; Bao, J.-K. Oridonin: An active diterpenoid targeting cell cycle arrest, apoptotic and autophagic pathways for cancer therapeutics. Int. J. Biochem. Cell Biol. 2011, 43, 701–704. DOI: 10.1016/j.biocel.2011.01.020.
   PubMed Web of Science ®Google Scholar
• Feng, N.; Wu, P.; Li, Q.; Mei, Y.; Shi, S.; Yu, J.; Xu, J.; Liu, Y.; Wang, Y. Oridonin-loaded poly (ε-caprolactone)–poly(ethylene oxide)–poly(ε-caprolactone) copolymer nanoparticles: Preparation, characterization, and antitumor activity on mice with transplanted hepatoma. J. Drug Targeting, 2008, 16, 479–485. DOI: 10.1080/10611860802102282.
   PubMed Web of Science ®Google Scholar
• Vasilcanu, R.; Vasilcanu, D.; Rosengren, L.; Natalishvili, N.; Sehat, B.; Yin, S.; Girnita, A.; Axelson, M.; Girnita, L.; Larsson, O. Picropodophyllin induces downregulation of the insulin-like growth factor 1 receptor: potential mechanistic involvement of Mdm2 and [beta]-arrestin1. Oncogene, 2007, 27, 1629–1638. DOI: 10.1038/sj.onc.1210797.
   PubMed Web of Science ®Google Scholar
• Zhao, J.; Wang, Y.; Luan, L. Star-Shaped Polycaprolactone-Polyethyleneglycol Copolymer Micelle-Like Nanoparticles for Picropodophyllin Delivery. J. Biomed. Nanotechnol. 2014, 10, 1627–1634. DOI: 10.1166/jbn.2014.1835.
   PubMed Web of Science ®Google Scholar
• Zhu, Z.; Li, Y.; Li, X.; Li, R.; Jia, Z.; Liu, B.; Guo, W.; Wu, W.; Jiang, X. Paclitaxel-loaded poly (N-vinylpyrrolidone)-b-poly(ε-caprolactone) nanoparticles: Preparation and antitumor activity in vivo. J. Controlled Release, 2010, 142, 438–446. DOI: 10.1016/j.jconrel.2009.11.002.
   PubMed Web of Science ®Google Scholar
• Li, X.; Xu, H.; Dai, X.; Zhu, Z.; Liu, B.; Lu, X. Enhanced in vitro and in vivo therapeutic efficacy of codrug-loaded nanoparticles against liver cancer. Int. J. Nanomed. 2012, 7, 5183–5190. DOI: 10.2147/IJN.S34886">10.2147/IJN.S34886.
   PubMed Web of Science ®Google Scholar
• Liu, Q.; Li, R.; Zhu, Z.; Qian, X.; Guan, W.; Yu, L.; Yang, M.; Jiang, X.; Liu, B. Enhanced antitumor efficacy, biodistribution and penetration of docetaxel-loaded biodegradable nanoparticles. Int. J. Pharm. 2012, 430, 350–358. DOI: 10.1016/j.ijpharm.2012.04.008.
   PubMed Web of Science ®Google Scholar
• Li, X.; Li, R.; Qian, X.; Ding, Y.; Tu, Y.; Guo, R.; Hu, Y.; Jiang, X.; Guo, W.; Liu, B. Superior antitumor efficiency of cisplatin-loaded nanoparticles by intratumoral delivery with decreased tumor metabolism rate. Eur. J. Pharm. Biopharm. 2008, 70, 726–734. DOI: 10.1016/j.ejpb.2008.06.016.
   PubMed Web of Science ®Google Scholar
• Shi, B.; Abrams, M.; Sepp-Lorenzino, L. Expression of Asialoglycoprotein Receptor 1 in Human Hepatocellular Carcinoma. J.Histochem. Cytochem. 2013, 61, 901–909. DOI: 10.1369/0022155413503662.
   PubMed Web of Science ®Google Scholar
• Zhou, N.; Zan, X.; Wang, Z.; Wu, H.; Yin, D.; Liao, C.; Wan, Y. Galactosylated chitosan–polycaprolactone nanoparticles for hepatocyte-targeted delivery of curcumin. Carbohydr. Polym. 2013, 94, 420–429. DOI: 10.1016/j.carbpol.2013.01.014.
   PubMed Web of Science ®Google Scholar
• Tao, W.; Zeng, X.; Zhang, J.; Zhu, H.; Chang, D.; Zhang, X.; Gao, Y.; Tang, J.; Huang, L.; Mei, L. Synthesis of cholic acid-core poly (Ɛ-caprolactone-ran-lactide)-b-poly(ethylene glycol) 1000 random copolymer as a chemotherapeutic nanocarrier for liver cancer treatment. Biomater. Sci. 2014, 2, 1262–1274. DOI: 10.1039/C4BM00134F.
   PubMed Web of Science ®Google Scholar
• Liu, Q.; Li, R.-T.; Qian, H.-Q.; Yang, M.; Zhu, Z.-S.; Wu, W.; Qian, X.-P.; Yu, L.-X.; Jiang, X.-Q.; Liu, B.-R. Gelatinase-stimuli strategy enhances the tumor delivery and therapeutic efficacy of docetaxel-loaded poly (ethylene glycol)-poly (ɛ-caprolactone) nanoparticles. Int. J. Nanomed. 2012, 7, 281–295. DOI: 10.2147/IJN.S26697">10.2147/IJN.S26697.
   PubMed Web of Science ®Google Scholar
• Deng, H.; Zhao, X.; Liu, J.; Deng, L.; Zhang, J.; Liu, J.; Dong, A. Reactive oxygen species (ROS) responsive PEG-PCL nanoparticles with pH-controlled negative-to-positive charge reversal for intracellular delivery of doxorubicin. J. Mater. Chem. B. 2015, 3, 9397–9408. DOI: 10.1039/C5TB01939G.
   PubMed Web of Science ®Google Scholar
• Matsumoto, A.; Stephenson-Brown, A. J.; Khan, T.; Miyazawa, H.; Cabral, H.; Kataoka, K.; Miyahara, Y. Heterocyclic boronic acids display sialic acid selective binding in a hypoxic tumor relevant acidic environment. Chem. Sci. 2017, 8, 6165–6170. DOI: 10.1039/c7sc01905j.
   PubMed Web of Science ®Google Scholar
• Tang, Z.; Zhang, L.; Wang, Y.; Li, D.; Zhong, Z.; Zhou, S. Redox-responsive star-shaped magnetic micelles with active-targeted and magnetic-guided functions for cancer therapy. Acta Biomater. 2016, 42, 1–15. DOI: 10.1016/j.actbio.2016.06.038">10.1016/j.actbio.2016.06.038.
   Web of Science ®Google Scholar
• Ma, Y.; Huang, L.; Song, C.; Zeng, X.; Liu, G.; Mei, L. Nanoparticle formulation of poly(ɛ-caprolactone-co-lactide)-d-α-tocopheryl polyethylene glycol 1000 succinate random copolymer for cervical cancer treatment. Polymer, 2010, 51, 5952–5959. DOI: 10.1016/j.polymer.2010.10.029.
   Web of Science ®Google Scholar
• Qing-Shan, L.; Li, C. Y.; Li, Z. L.; Zhu, H. L. Genistein and its Synthetic Analogs as Anticancer Agents. Anti-Cancer Agents Med. Chem. 2012, 12, 271–281. DOI: 10.2174/187152012800228788.
   PubMed Web of Science ®Google Scholar
• Zhang, H.; Liu, G.; Zeng, X.; Wu, Y.; Yang, C.; Mei, L.; Wang, Z.; Huang, L. Fabrication of genistein-loaded biodegradable TPGS-b-PCL nanoparticles for improved therapeutic effects in cervical cancer cells. Int. J. Nanomed. 2015, 10, 2461–2473. DOI: 10.2147/IJN.S78988">10.2147/IJN.S78988.
   PubMed Web of Science ®Google Scholar
• Yang, X.; Chen, Y.; Yuan, R.; Chen, G.; Blanco, E.; Gao, J.; Shuai, X. Folate-encoded and Fe3O4-loaded polymeric micelles for dual targeting of cancer cells. Polymer, 2008, 49, 3477–3485. DOI: 10.1016/j.polymer.2008.06.005.
   Web of Science ®Google Scholar
• Weiß, L.; Efferth, T. Polo-like kinase 1 as target for cancer therapy. Exp.Hematol. Oncol. 2012, 1, 1–6. DOI: 10.1186/2162-3619-1-38">10.1186/2162-3619-1-38.
   PubMedGoogle Scholar
• Lin, D.; Jiang, Q.; Cheng, Q.; Huang, Y.; Huang, P.; Han, S.; Guo, S.; Liang, Z.; Dong, A. Polycation-detachable nanoparticles self-assembled from mPEG-PCL-g-SS-PDMAEMA for in vitro and in vivo siRNA delivery. Acta Biomater. 2013, 9, 7746–7757. DOI: 10.1016/j.actbio.2013.04.031.
   PubMed Web of Science ®Google Scholar
• Gou, M.; Zheng, L.; Peng, X.; Men, K.; Zheng, S.; Guo, G.; Luo, F.; Zhao, X.; Chen, L.; Wei, Y.; et al. Poly(ɛ-caprolactone)–poly(ethylene glycol)–poly(ɛ-caprolactone) (PCL–PEG–PCL) nanoparticles for honokiol delivery in vitro. Int. J. Pharm. 2009, 375, 170–176. DOI: 10.1016/j.ijpharm.2009.04.007.
   PubMed Web of Science ®Google Scholar
• Gou, M.; Zheng, X.; Men, K.; Zhang, J.; Wang, B.; Lv, L.; Wang, X.; Zhao, Y.; Luo, F.; Wei, Y.; et al. Self-Assembled Hydrophobic Honokiol Loaded MPEG-PCL Diblock Copolymer Micelles. Pharm. Res. 2009, 26, 2164–2173. DOI: 10.1007/s11095-009-9929-8.
   PubMed Web of Science ®Google Scholar
• Zheng, D.; Li, D.; Lu, X.; Feng, Z. Enhanced antitumor effciency of docetaxel-loaded nanoparticles in a human ovarian xenograft model with lower systemic toxicties by intratumoral delivery. Oncol. Rep. 2010, 23, 717–724. DOI: 10.3892/or_00000689">10.3892/or_00000689.
   PubMed Web of Science ®Google Scholar
• Xu, P.; Van Kirk, E. A.; Murdoch, W. J.; Zhan, Y.; Isaak, D. D.; Radosz, M.; Shen, Y. Anticancer Efficacies of Cisplatin-Releasing pH-Responsive Nanoparticles. Biomacromolecules, 2006, 7, 829–835. DOI: 10.1021/bm050902y.
   PubMed Web of Science ®Google Scholar
• van Vlerken, L. E.; Duan, Z.; Seiden, M. V.; Amiji, M. M. Modulation of Intracellular Ceramide Using Polymeric Nanoparticles to Overcome Multidrug Resistance in Cancer. Cancer Res. 2007, 67, 4843–4850. DOI: 10.1158/0008-5472.CAN-06-1648.
   PubMed Web of Science ®Google Scholar
• Devalapally, H.; Duan, Z.; Seiden, M. V.; Amiji M. M. Paclitaxel and ceramide co-administration in biodegradable polymeric nanoparticulate delivery system to overcome drug resistance in ovarian cancer. Int. J. Cancer. 2007, 121, 1830–1838. DOI: 10.1002/ijc.22886.
   PubMed Web of Science ®Google Scholar
• Devalapally, H.; Duan, Z.; Seiden, M. V.; Amiji, M. M. Modulation of Drug Resistance in Ovarian Adenocarcinoma by Enhancing Intracellular Ceramide Using Tamoxifen-Loaded Biodegradable Polymeric Nanoparticles. Clin.Cancer Res. 2008, 14, 3193–3203. DOI: 10.1158/1078-0432.CCR-07-4973.
   PubMed Web of Science ®Google Scholar
• Yadav, S.; Van Vlerken, L. E.; Little, S. R.; Amiji, M. M. Evaluations of combination MDR-1 gene silencing and paclitaxel administration in biodegradable polymeric nanoparticle formulations to overcome multidrug resistance in cancer cells. Cancer Chemother. Pharmacol. 2009, 63, 711–722. DOI: 10.1007/s00280-008-0790-y.
   PubMed Web of Science ®Google Scholar
• Scarano, W.; De Souza, P.; Stenzel, M. Dual-drug delivery of curcumin and platinum drugs in polymeric micelles enhances the synergistic effects: a double act for the treatment of multidrug-resistant cancer. Biomater. Sci. 2015, 3, 163–174. DOI: 10.1039/C4BM00272E.
   PubMed Web of Science ®Google Scholar
• Bilensoy, E.; Sarisozen, C.; Esendaĝli, G.; Doĝan, A. L.; Aktaş, Y.; Sen, M.; Mungan, N. A. Intravesical cationic nanoparticles of chitosan and polycaprolactone for the delivery of Mitomycin C to bladder tumors. Int. J. Pharm. 2009, 371, 170–176. DOI: 10.1016/j.ijpharm.2008.12.015.
   PubMed Web of Science ®Google Scholar
• Erdogar, N.; Iskit, A. B.; Eroglu, H.; Sargon, M. F.; Mungan, N. A.; Bilensoy, E. Cationic core-shell nanoparticles for intravesical chemotherapy in tumor-induced rat model: Safety and efficacy. Int. J. Pharm. 2014, 471, 1–9. DOI: 10.1016/j.ijpharm.2014.05.014.
   PubMed Web of Science ®Google Scholar
• Zhang, H.; Li, X.; Ding, J.; Xu, H.; Dai, X.; Hou, Z.; Zhang, K.; Sun, K.; Sun, W. Delivery of ursolic acid (UA) in polymeric nanoparticles effectively promotes the apoptosis of gastric cancer cells through enhanced inhibition of cyclooxygenase 2 (COX-2). Int. J. Pharm. 2013, 441, 261–268. DOI: 10.1016/j.ijpharm.2012.11.034.
   PubMed Web of Science ®Google Scholar
• Li, X.; Lu, X.; Xu, H.; Zhu, Z.; Yin, H.; Qian, X.; Li, R.; Jiang, X.; Liu, B. Paclitaxel/Tetrandrine Coloaded Nanoparticles Effectively Promote the Apoptosis of Gastric Cancer Cells Based on “Oxidation Therapy”. Mol. Pharmaceutics, 2012, 9,222–229. DOI: 10.1021/mp2002736.
   PubMed Web of Science ®Google Scholar
• Zhang, H.; Tian, Y.; Zhu, Z.; Xu, H.; Li, X.; Zheng, D.; Sun, W. Efficient antitumor effect of co-drug-loaded nanoparticles with gelatin hydrogel by local implantation. Sci. Rep. 2016, 6, 1–14. DOI: 10.1038/srep26546">10.1038/srep26546.
   PubMed Web of Science ®Google Scholar
• Krishnan, V.; Xu, X.; Barwe, S. P.; Yang, X., Czymmek, K.; Waldman, S. A.; Mason, R. W.; Jlia, X.; Rajasekaran, A. K. Dexamethasone-Loaded Block Copolymer Nanoparticles Induce Leukemia Cell Death and Enhance Therapeutic Efficacy: A Novel Application in Pediatric Nanomedicine. Mol. Pharmaceutics, 2013, 10, 2199–2210. DOI: 10.1021/mp300350e.
   PubMed Web of Science ®Google Scholar
• Cortese, B.; D’Amone, S.; Gigli, G.; Palamà, I. E. Sustained anti-BCR-ABL activity with pH responsive imatinib mesylate loaded PCL nanoparticles in CML cells. Med. Chem. Commun. 2015, 6, 212–221. DOI: 10.1039/C4MD00348A.
   Web of Science ®Google Scholar
• Amgoth, C.; Dharmapuri, G. Synthesis and Characterization of Polymeric Nanoparticles and Capsules as Payload for Anticancer Drugs and Nanomedicines. Mater. Today, 2016 , 3, 3833–3837. DOI: 10.1016/j.matpr.2016.11.036.
   Google Scholar
• Hira, S. K.; Mishra, A. K.; Ray, B.; Manna, P. P. Targeted Delivery of Doxorubicin-Loaded Poly (ε-caprolactone)-b-Poly(N-vinylpyrrolidone) Micelles Enhances Antitumor Effect in Lymphoma. PLoS One, 2014, 9, 1–17. DOI: 10.1371/journal.pone.0094309">10.1371/journal.pone.0094309.
   Web of Science ®Google Scholar
• Zheng, L.; Gou, M.; Zhou, S.; Yi, T.; Zhong, Q.; Li, Z.; He, X.; Chen, X.; Zhou, L.; Wei, Y.; et al. Antitumor activity of monomethoxy poly (ethylene glycol)-poly(ε-caprolactone) micelle-encapsulated doxorubicin against mouse melanoma. Oncol. Rep. 2011, 25, 1557–1564. DOI: 10.3892/or.2011.1243">10.3892/or.2011.1243.
   PubMed Web of Science ®Google Scholar
• Loch-Neckel, G.; Santos-Bubniak, L.; Mazzarino, L.; Jacques, A. V.; Moccelin, B.; Santos-Silva, M. C.; Lemos-Senna, E. Orally Administered Chitosan-Coated Polycaprolactone Nanoparticles Containing Curcumin Attenuate Metastatic Melanoma in the Lungs. J. Pharm. Sci. 2015, 104, 3524–3534. DOI: 10.1002/jps.24548.
   PubMed Web of Science ®Google Scholar
• Yu, H.; Chen, J.; Liu, S.; Lu, Q.; He, J.; Zhou, Z.; Hu, Y. Enzyme sensitive, surface engineered nanoparticles for enhanced delivery of camptothecin. J. Controlled Release, 2015, 216, 111–120. DOI: 10.1016/j.jconrel.2015.08.021.
   PubMed Web of Science ®Google Scholar
• Semenza, G. L. Defining the Role of Hypoxia-Inducible Factor 1 in Cancer Biology and Therapeutics. Oncogene, 2010, 29, 625–634. DOI: 10.1038/onc.2009.441.
   PubMed Web of Science ®Google Scholar
• Chen, Y.; Xu, G.; Zheng, Y.; Yan, M.; Li, Z.; Zhou, Y.; Mei, L.; Li, X. Nanoformulation of D-α-tocopheryl polyethylene glycol 1000 succinate-b-poly(ε-caprolactone-ran-glycolide) diblock copolymer for siRNA targeting HIF-1α for nasopharyngeal carcinoma therapy. Int. J. Nanomed. 2015, 10, 1375–1386. DOI: 10.2147/IJN.S76092">10.2147/IJN.S76092.
   PubMed Web of Science ®Google Scholar
• Lian, D.; Chen, Y.; Xu, G.; Zeng, X.; Li, Z.; Li, Z.; Zhou, Y.; Mei, L.; Li, X. Delivery of siRNA targeting HIF-1α loaded chitosan modified d-α-tocopheryl polyethylene glycol 1000 succinate-b-poly(ε-caprolactone-ran-glycolide) nanoparticles into nasopharyngeal carcinoma cell to improve the therapeutic efficacy of cisplatin. RSC Adv. 2016, 6, 37740–37749. DOI:10.1039/C6RA03440C.
   Web of Science ®Google Scholar
• Gang, J.; Park, S. B.; Hyung, W.; Choi, E. H.; Wen, J.; Kim, H. S.; Shul, Y. G, Haam, S.; Song, S. Y. Magnetic poly ε-caprolactone nanoparticles containing Fe3O4 and gemcitabine enhance anti-tumor effect in pancreatic cancer xenograft mouse model. J. Drug Targeting, 2007, 15, 445–453. DOI: 10.1080/10611860701453901.
   PubMed Web of Science ®Google Scholar
• Sanna, V.; Roggio, A. M.; Posadino, A. M.; Cossu, A.; Marceddu, S.; Mariani, A.; Alzari, V.; Uzzau, S.; Pintus, G.; Sechi, M.; et al. Novel docetaxel-loaded nanoparticles based on poly (lactide-co-caprolactone) and poly(lactide-co-glycolide-co-caprolactone) for prostate cancer treatment: formulation, characterization, and cytotoxicity studies. Nanoscale Res. Lett. 2011, 6, 1–9. DOI: 10.1186/1556-276X-6-260.
   Web of Science ®Google Scholar
• Sanna, V.; Siddiqui, I. A.; Sechi, M.; Mukhtar, H. Resveratrol-Loaded Nanoparticles Based on Poly (epsilon-caprolactone) and Poly(d,l-lactic-co-glycolic acid)–Poly(ethylene glycol) Blend for Prostate Cancer Treatment. Mol. Pharmaceutics, 2013, 10, 3871–3881. DOI:10.1021/mp400342f.
   PubMed Web of Science ®Google Scholar
• Arya, A.; Khandelwal, K.; Ahmad, H.; Laxman, T. S.; Sharma, K.; Mittapelly, N.; Agrawal, S.; Bhatta, R. S.; Dwivedi, A. K. Co-delivery of hesperetin enhanced bicalutamide induced apoptosis by exploiting mitochondrial membrane potential via polymeric nanoparticles in a PC-3 cell line. RSC Adv. 2016, 6, 5925–5935. DOI:10.1039/C5RA23067E.
   Web of Science ®Google Scholar
• Zhao, Y.; Duan, S.; Zeng, X.; Liu, C.; Davies, N. M.; Li, B.; Forrest, M. L. Prodrug Strategy for PSMA-Targeted Delivery of TGX-221 to Prostate Cancer Cells. Mol. Pharmaceutics, 2012, 9, 1705–1716. DOI: 10.1021/mp3000309.
   PubMed Web of Science ®Google Scholar
• Zhang, L.; Yang, M.; Wang, Q.; Li, Y.; Guo, R.; Jiang, X.; Yang, C.; Liu, B. 10-Hydroxycamptothecin loaded nanoparticles: Preparation and antitumor activity in mice. J. Controlled Release, 2007, 119, 153–162. DOI: 10.1016/j.jconrel.2007.02.013.
   PubMed Web of Science ®Google Scholar
• Kanazawa, T.; Sugawara, K.; Tanaka, K.; Horiuchi, S.; Takashima, Y.; Okada, H. Suppression of tumor growth by systemic delivery of anti-VEGF siRNA with cell-penetrating peptide-modified MPEG–PCL nanomicelles. Eur. J. Pharm. Biopharm. 2012, 81, 470–477. DOI: 10.1016/j.ejpb.2012.04.021.
   PubMed Web of Science ®Google Scholar
• Tanaka, K.; Kanazawa, T.; Horiuchi, S.; Ando, T.; Sugawara, K.; Takashima, Y.; Seta, Y.; Okada, H. Cytoplasm-responsive nanocarriers conjugated with a functional cell-penetrating peptide for systemic siRNA delivery. Int. J. Pharm. 2013, 455, 40–47. DOI: 10.1016/j.ijpharm.2013.07.069.
   PubMed Web of Science ®Google Scholar
• Yadav, A. K.; Mishra, P.; Jain, S.; Mishra, P.; Mishra, A. K.; Agrawal, G. P. Preparation and characterization of HA–PEG–PCL intelligent core–corona nanoparticles for delivery of doxorubicin. J. Drug Targeting, 2008, 16, 464–478. DOI: 10.1080/10611860802095494.
   PubMed Web of Science ®Google Scholar
• Huang, P.; Yang, C.; Liu, J.; Wang, W.; Guo, S.; Li, J.; Sun, Y.; Dong, H.; Deng, L.; Zhang, J.; et al. Improving the oral delivery efficiency of anticancer drugs by chitosan coated polycaprolactone-grafted hyaluronic acid nanoparticles. J. Mater. Chem. B2014, 2, 4021–4033. DOI: 10.1039/C4TB00273C.
   PubMed Web of Science ®Google Scholar